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Abstract 
Riitta Räty. Laboratory Diagnosis and Surveillance of Acute Respiratory Infections 
Caused by Certain Common Viruses and Mycoplasma pneumoniae. National Institute 
for Health and Welfare (THL). Research 115. 111 pages. Helsinki, Finland 2013 
ISBN 978-952-302-006-1 (printed); ISBN 978-952-302-007-8 (pdf) 
 
Respiratory infections are the most common illnesses worldwide, and a large frac-
tion of those are of viral origin. These infections are associated with significant 
morbidity and mortality as well as substantial socio-economic impact. Rapid identi-
fication of a causing agent provides guidance for treatment decisions and may help 
prevent the further spread of the microbe.  
Adenoviruses frequently cause outbreaks of respiratory infections in army train-
ing centers. Different laboratory methods, including virus antigen detection by IF, 
TR-FIA and EIA, conventional culture, rapid culture, PCR, and serology by CFT, 
have been applied for diagnosing adenovirus infections in military conscripts. In that 
study the diagnostic efficacy of different methods was compared. An almost equal 
number of diagnoses was achieved by PCR and by virus culture, while virus antigen 
detection by EIA and TR-FIA was considerably less sensitive. Also sero-diagnosis 
by CFT identified significant rises of antibody titers in patients who remained nega-
tive by virus antigen tests.  
Acute otitis media is a common complication of upper respiratory tract infection 
in young children. The role of Mycoplasma pneumoniae in the etiology of AOM is 
poorly understood. A PCR for the partial amplification of the P1 gene was devel-
oped and applied for the detection of M. pneumoniae in NPA and MEF specimens 
from children with AOM. Antibodies to M. pneumoniae were measured by CFT and 
by EIA. In 4 % of the MEF specimens M. pneumoniae was detected by PCR. Sero-
logical results did not consistently support the PCR findings. 
The Finnish Otitis Media (FinOM) study provided an excellent opportunity to deter- 
mine the etiology of this disease and to evaluate different laboratory diagnostic methods. 
From children presenting with AOM, NPA, MEF, as well as acute and convalescent 
phase serum were collected. NPAs and MEFs were tested for the presence of respi-
ratory virus antigens by TR-FIA. Antibodies to the same viruses were measured by 
CFT or EIA. In one third of the cases a viral etiology could be established by antigen detec-
tion and/or by serology. RSV was the most frequently identified virus in this mate-
rial. In this study, significantly more diagnoses were established by serology than by 
direct virus antigen detection. 
The quality of the clinical specimen greatly influences the sensitivity of labora-
tory diagnosis. In an attempt to evaluate the optimal specimen for the detection of 
M. pneumoniae by PCR in patients with X-ray confirmed pneumonia, sputum, throat 
swab, and NPA were collected from hospitalized patients. In addition, acute and 
convalescent phase serum specimens were obtained. In this comparison, sputum has 
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been found to be the best respiratory specimen. In two thirds of the patients from 
whom all specimens were available, M. pneumoniae could be detected by PCR in 
the sputum. Serological findings well supported the results obtained by PCR.  
In a long-term surveillance of respiratory infections in certain segments of the 
Finnish population, 7 common respiratory viruses were monitored by antigen detec-
tion using TR-FIA. From many patients, also acute and convalescent phase serum 
specimens were available for measurement of antibodies by CFT. Over a period of 
16 years, influenza epidemics have been observed each winter. While RSV was the 
predominant virus in small children, adenoviruses were the most frequently identi-
fied pathogen in army recruits. Although serological results are rarely available dur-
ing the acute phase of a respiratory infection, also in this study, more diagnostic 
findings were obtained by CFT as compared to virus antigen detection. 
 
Keywords: respiratory infections, respiratory viruses, M. pneumoniae, clinical 
specimen, laboratory diagnosis, antigen detection, PCR, virus culture, serology 
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Tiivistelmä 
Riitta Räty. Akuuttien hengitystieinfektioiden laboratoriodiagnostiikka muutaman 
tärkeimmän viruksen ja Mycoplasma pneumoniae-bakteerin valossa sekä näiden 
infektioiden epidemiologisesta seurannasta. Terveyden ja hyvinvoinnin laitos 
(THL). Tutkimus 115. 111 sivua. Helsinki, Suomi 2013. 
ISBN 978-952-302-006-1 (painettu); ISBN 978-952-302-007-8 (pdf) 
 
Hengitystieinfektiot ovat maailman yleisimpiä sairauksia ja suurin osa niistä on 
virusten aiheuttamia. Näihin infektioihin liittyy suuri sairastavuus ja merkittävä 
kokonaiskuolleisuus, joten niiden yhteiskunnallinen ja taloudellinen vaikutus voi 
olla huomattava. Aiheuttajan nopea tunnistaminen auttaa valitsemaan oikeat hoito-
toimenpiteet ja vähentämään infektion leviämistä ympäristöön. 
Adenovirukset aiheuttavat usein hengitystie-infektioryppäitä varuskunnissa. Va-
rusmiesten adenovirusinfektioiden diagnostisoimiseksi on kehitetty useita eri labora-
toriomenetelmiä kuten virusantigeenidetektio IF:lla, TR-FIA:lla tai EIA:lla, perin-
teinen virusviljely, pikaviljely, PCR ja virusserologia CF-testillä. Tässä työssä näi-
den menetelmien diagnostista ottavuutta verrattiin toisiinsa. Suurin piirtein yhtä 
paljon diagnooseja tehtiin PCR:llä ja virusviljelyllä kun taas antigeenidetektio TR-
FIA:lla ja EIA:lla olivat paljon epäherkempiä. Myös CF-serologia löysi merkittäviä 
vasta-ainenousuja potilailla, jotka jäivät antigeenidetektiossa negatiivisiksi.  
Akuutti välikorvantulehdus on yleinen hengitystieinfektion komplikaatio lapsilla. 
M.pneumoniaen osuudesta välikorvantulehduksissa on ollut hyvin vähän tietoa. 
Tässä työssä kehitettiin PCR-menetelmä, jolla voitiin monistaa osa P1-geeniä ja 
sovellusta käytettiin M.pneumoniaen havaitsemiseksi korvatulehduslasten NPA ja 
MEF-näytteistä. M.pneumoniae-vasta-aineita etsittiin CF- testillä ja EIA:lla. Neljä 
prosenttia MEF-näytteistä oli positiivisia M.pneumoniaen suhteen PCR:llä. Serolo-
gian ja PCR-testin tulokset olivat vain pieneltä osalta yhteneväisiä.  
FinOM-tutkimus tarjosi erinomaisen tilaisuuden tutkia välikorvatulehdusten mik-
robietiologiaa ja  eri menetelmien  diagnostista ottavuutta. Lapsilta, joilla välikor-
vantulehdus todettiin, otettiin NPA- ja MEF-näytteet sekä kerättiin pariverinäytteet 
(akuutin ja toipilasvaiheen verinäytteet). NPA ja MEF-näytteistä tutkittiin virusanti-
geenit TR-FIA:lla. Vasta-aineet näitä viruksia vastaan tutkittiin CF-testillä. Kolmas-
osassa tapauksista voitiin virusetiologia todeta joko antigeenidetektiolla tai serologi-
sesti. RSV oli yleisin viruslöydös tässä aineistossa. Diagnooseja tehtiin huomatta-
vasti enemmän serologisen testin avulla kuin antigeenidetektiolla.  
Näytetyyppi vaikuttaa merkittävästi diagnostisten testien herkkyyteen. Potilailta, 
joilla oli röntgenologisesti todettu keuhkokuume, kerättiin yskös, imulima ja nenä-
nielutikkunäyte sen arvioimiseksi mikä näistä näytetyypeistä olisi ihanteellisin 
M.pneumoniaen PCR-diagnostiikkaa varten. Lisäksi potilailta kerättiin myös  pa-
riseeruminäytteet. Vertailu osoitti, että M.pneumoniae löytyi useimmin yskösnäyt-
teestä PCR:llä. Serologian ja PCR-testin tulosten yhteneväisyys oli hyvä. 
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Pitkän aikavälin hengitystieinfektioiden seurantaan osallistui eri väestönosia 
Suomessa ja seurannan aikana haettiin antigeenidetektion (TR-FIA) avulla seitse-
män tavallista hengitystievirusta. Suuresta osasta tutkittavia oli myös otettu parisee-
ruminäytteet ja niistä tutkittiin mahdolliset mikrobivasta-ainetasojen nousut CF-
testin avulla. Kuudentoista vuoden aikana on joka talvi esiintynyt influenssaepide-
mioita. RSV oli vallitseva virus pikkulapsilla, kun taas adenovirus oli yleisin varus-
miehillä tavattu patogeeni. Vaikka serologisia tuloksia harvoin on käytössä hengitys-
tieinfektion akuutissa vaiheessa, löytyy serologian avulla usein, kuten tässäkin tut-
kimuksessa, enemmän diagnooseja CF-testillä kuin virusantigeenidetektiolla. 
 
 
 
Avainsanat: hengitystieinfektiot, respiratoriset virukset, M. pneumoniae, kliiniset 
näytteet, laboratoriodiagnostiikka, antigeenidetektio, PCR, virusviljely, serologia 
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Sammandrag 
Riitta Räty. Diagnostisering och övervakning av akuta respiratoriska infektioner 
orsakade av de sju vanligaste respiratoriska virusen och Mycoplasma pneumoniae. 
Institutet för hälsa och välfärd (THL). Forskning 115. 111 sidor. Helsingfors, Fin-
land 2013. 
ISBN 978-952-302-006-1 (tryckt); ISBN 978-952-302-007-8 (pdf) 
 
Luftvägsinfektioner är de vanligaste smittsamma sjukdomarna i hela världen, och en 
stor del av dem är av viralt ursprung. Dessa infektioner är förknippade med hög 
sjuklighet och dödlighet, och kan ha betydande socioekonomiska effekter.  Snabb 
identifiering av den orsakande patogenen ger vägledning för behandlingsbeslut och 
kan bidra till att förhindra ytterligare spridning av patogenen. 
Adenovirus orsakar ofta utbrott av luftvägsinfektioner i arméns utbildnings-
center. Olika laboratoriemetoder, inclusive virusantigen påvisning med IF, TR-FIA 
eller EIA, konventionell kultur, snabbkultur, PCR och serologi med CFT, har 
tillämpats för att diagnostisera adenovirus-infektioner hos de värnpliktiga inom 
armén. Den diagnostiska effektiviteten hos dessa metoder jämfördes med varandra. 
Ett nästan lika stort antal diagnoser uppnåddes med PCR och med virusodling, 
medan virusantigen påvisning med EIA eller TR-FIA var avsevärt mindre känslig. 
Sero-diagnos genom CFT identifierade betydande ökningar av antikroppstitrar hos 
patienter vars prov i virusantigen-tester gav negativa resultat. 
Akut öroninflammation (AOM) är en vanlig komplikation vid övre luftvägsin-
fektion hos små barn. Vilken roll M. pneumoniae spelar i etiologin av AOM förstår 
man ännu ganska dåligt. En PCR utvecklades och tillämpades för detektion av M. 
pneumoniae för amplification av en del av P1-genen i NPA- och MEF-prov från 
barn med AOM. Antikroppar mot M. pneumoniae mättes genom CFT och PCR. I 4 
% av MEF-proven detekterades M. pneumoniae med PCR.  Serologiska resultat 
stödde inte PCR resultaten.  
Den finska öroninflammationsstudien (FinOM) gav ett utmärkt tillfälle för att 
bestämma etiologin av denna sjukdom och för att utvärdera olika laboratoriediag-
nostiska metoder. Från barn som uppvisade AOM, samlades NPA, MEF samt blod-
prov under den akuta fasen och konvalescensfasen. NPA- och MEF-proven testades 
med avseende på förekomst av respiratoriska virusantigener med TR-FIA. Antik-
roppar mot samma virus mättes genom CFT eller EIA. I en tredjedel av fallen kunde  
en viral etiologi konstateras genom antigendetektion och/eller serologi. RSV var det  
oftast identifierade viruset i materialet. I denna studie fanns betydligt fler diagnoser  
som konstaterats genom serologi än genom direkt upptäckt av virusantigen. 
 Kvaliteten på kliniska prov påverkar laboratoriediagnosens känslighet i hög 
grad. I ett försök att utvärdera den optimala provtypen för detektion av M. pneu-
moniae med PCR hos patienter med en röntgenbekräftad lunginflammation, sam-
lades sputum, näs-hals och NPA-prov. Dessutom samlades blodprov under den 
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akuta fasen och konvalescens-fasen. I denna jämförelse var sputum det bästa respira-
toriska provet. I två tredjedelar av patienter från vilka alla prov var tillgängliga, 
detekterades M. pneumoniae från sputum. Serologiska resultaten stödde väl PCR 
resultaten. 
I en långsiktig bevakning av luftvägsinfektioner hos vissa befolkningsgrupper i 
Finland, söktes sju vanliga respiratoriska virus med antigendetektion (TR-FIA).  
Från en stor andel patienter fanns det också serumprov som tagits under den akuta 
fasen och konvalescentfasen, som kunde användas för mätning av antikroppar med 
CFT. Under en period på sexton år, har influensaepidemier observerats varje vinter. 
Medan RSV var det dominerande viruset hos små barn, var adenovirus den oftast 
identifierade patogenen hos de värnpliktiga. Även om serologiska resultat sällan är 
tillgängliga under den akuta fasen av luftvägsinfektioner, ger de ofta, likt i denna 
studie, mera diagnostiska resultat genom CFT jämfört med påvisning av virusanti-
gen.  
 
Nyckelord: luftvägsinfektioner, kliniska prov, repiratoriska virus, M. pneumoniae 
laboratoriediagnostik, antigen, PCR, virus kultur, serologi 
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1 Introduction 
Respiratory infections are the most common illnesses worldwide, causing significant 
morbidity and mortality. The clinical picture can vary from mild, even subclinical to 
severe, sometimes fatal infection. Acute upper respiratory infections are often of 
viral etiology. Many of the causing agents are readily transmitted from human to 
human and thus often cause sizeable epidemics that may be limited locally or can 
spread nationally or internationally. Laboratory diagnosis and surveillance of res-
piratory infections are crucial for many reasons. Rapid identification of the causing 
agent can direct decisions concerning optimal antimicrobial or symptomatic treat-
ment strategies. The recognition of the causative agent may help prevent further 
spread of the pathogen by guiding decisions about cohorting individuals infected 
with the same pathogen or by reducing social contacts. Through detailed characteri-
zation of influenza viruses, suitable candidate vaccine viruses can be identified. 
Laboratory-based diagnosis and surveillance applying conventional and molecular 
methods can help identify new, previously unknown or unidentified pathogens. It 
also can assist early recognition of significant changes in a certain agent, such as the 
sudden emergence of drug-resistant influenza viruses, influenza viruses with un-
common characteristics, or changes that may alter the virulence or pathogenicity of 
a virus. Laboratory diagnostic results help understand the epidemiology and clinical 
characteristics of certain pathogens. 
Although many clinical laboratories offer testing for several respiratory patho-
gens, national and international surveillance is usually limited to influenza A and B 
viruses, and to some other viruses. Over a period of 16 years, from 1989 to 2005, it 
was attempted to establish a microbiological etiology for 12,020 patients with res-
piratory infection. Samples were analyzed for adenoviruses, influenza virus types A 
and B, parainfluenza virus types 1 – 3, respiratory syncytial virus (RSV), and M. 
pneumoniae. Viral antigens were detected using time-resolved fluoroimmunoassays 
(TR-FIA) and antibodies to all pathogens mentioned were measured with comple-
ment fixation test. 
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2 Review of the Literature 
2.1 Novel respiratory Viruses 
Using modern diagnostic laboratory methods, an etiological agent can be detected in 
almost every patient presenting with signs and symptoms of an acute respiratory 
tract infection. Many of the common respiratory viruses have been identified be-
tween the 1930s and 1950s, and their clinical and epidemiological significance has 
been well established. Occasionally new respiratory pathogens are introduced into 
the human population by transmission of animal viruses to humans. In addition, with 
novel, molecular methods that have become available during recent years, new or 
previously unrecognized viruses have been identified (Table 1). 
Middle East Respiratory Syndrome Coronavirus (MERS-Coronavirus). As 
recently as in summer 2012, a 60-year old man in Saudi-Arabia was hospitalized due 
to an acute severe pneumonia and subsequent kidney failure. From a sputum sample 
taken early after hospital admission, a novel coronavirus, likely originating from 
bats, was identified (Anderson and Baric 2012; Zaki, van Boheemen et al. 2012). A 
second patient transferred from the Middle East to the United Kingdom in the fall of 
2012, harboured almost an identical virus in his respiratory secretions (Bermingham, 
Chand et al. 2012). Within a very short time, specific diagnostic tests were devel-
oped and control reagents were made available to diagnostic laboratories (Corman, 
Eckerle et al. 2012).  
Coronaviruses NL63 and HKU1. The SARS epidemic stimulated intense re-
search of coronaviruses and within a short period of time two new coronaviruses, 
coronavirus NL-63 and coronavirus HKU1, were detected (van der Hoek, Pyrc et al. 
2004; Woo, Lau et al. 2005). Both of these viruses have evidently been human 
pathogens for many years and it is now understood that these viruses cause acute 
respiratory infections (Jartti, Jartti et al. 2012).  
SARS coronavirus. The occurrence of MERS-coronavirus generated fears that a 
similar epidemic as that caused by SARS coronavirus in 2003 might evolve. In 
southern China cases of atypical pneumonia were observed in individuals who had 
contact with civet cats late in 2002. After the epidemic spread to Hong Kong, the 
causative agent of the illness was rapidly identified as a previously unknown coro-
navirus (Drosten, Gunther et al. 2003; Ksiazek, Erdman et al. 2003; Peiris, Lai et al. 
2003; Tsang, Ho et al. 2003). Over the following weeks and months, the epidemic 
spread to 26 countries, and over 8000 cases including 774 deaths have been observed 
(Peiris, Yuen et al. 2003). Rapid, effective public health measures and close interna-
tional scientific cooperation enabled the successful containment of the epidemic al-
ready in summer of 2003 and the outbreak ended (Peiris, Yuen et al. 2003). It is be-
lieved that also the SARS-coronavirus originated from bats (Wang, Shi et al. 2006). 
Review of the Literature 
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Influenza A(H7N9). Just recently, in March 2013, severe respiratory infections 
with multiple deaths occurred in Eastern China around the Shanghai area. The cau-
sative agent was rapidly identified and it was found to be triple assortant virus. The 
virus likely obtained the H7 gene from a duck H7N3 virus, the N9 gene from a 
Korean H7N9 virus, and the rest of the genes from an avian H9N2 virus (Gao, Lu et 
al. 2013; Gao, Cao et al. 2013). By April 18, 2013, altogether 83 human cases have 
been identified with 17 deaths (http://www.chinacdc.cn/en/research_5311).  
Influenza A (H3N2v; H1N2v; H1N1v). Between August 2011 and October 
2012, 319 human infections with a swine-origin H3N2 influenza virus (H3N2v) 
have been reported to the Centers for Disease Control and Prevention, Atlanta 
http://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm (accessed November 7, 
2012). This virus was first transmitted from pigs to humans in the summer of 2011 
in the United States. Most infected individuals have been in close contact with pigs, 
particularly at agricultural fairs. After several months of absence, the virus reoc-
curred in summer 2012 in several states of the USA. Meanwhile the virus had ob-
tained through reassortment the gene segment 7 coding for the M1 and M2 proteins 
from the influenza A(H1N1)pdm09 virus, i.e., the swine origin virus that caused the 
pandemic in 2009 http://www.cdc.gov/flu/spotlights/h3n2v_us_cases.htm (accessed 
November 7, 2012). Most of these human cases have been relatively mild and 
there is little evidence for human-to-human transmission. In addition to these cases 
caused by the influenza A(H3N2v) strain, also a few human cases of H1N2v and 
H1N1v have been reported. These influenza viruses of swine origin could present a 
pandemic threat, particularly if they should gain the ability to easily spread among 
humans. In some studies it has been shown, however, that certain segments of the 
population, particularly individuals >10 years of age, have cross-reactive anti-
bodies against the H3N2v virus which may confer some protection 
(http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6114a1.htm) (accessed November 
7, 2012) (Waalen, Kilander et al. 2012). This H3N2v virus has obtained its hemag-
glutinin gene from a human virus that has been transmitted to pigs in the mid 1990s 
(Webby, Swenson et al. 2000). 
Influenza A triple-reassortant. Similar incidences of influenza virus transmis-
sion from pig to human have occurred previously. Triple-reassortant influenza A 
virus of the subtype H1N1 became enzootic in North American pigs in the late 
1990s (Shinde, Bridges et al. 2009). After multiple reassortment events, this virus 
had 5 gene segments (HA, NP, NA, M, NS) from the classic North American swine 
lineage, 2 from the avian North American lineage (PB2, PA), and the PB1 gene 
segment from a seasonal human influenza A(H3N2) virus. Between December 2005 
and February 2009, this virus has caused 10 sporadic cases in humans in the United 
States. Most of these patients showed symptoms of typical influenza infection, two 
of them had X-ray confirmed pneumonia and all patients recovered (Shinde, Bridges 
et al. 2009).  
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Influenza A(H1N1)pdm09. Before evolving into a pandemic virus, this triple 
reassortant virus exchanged two gene segments (NA and M) with those of a virus 
belonging to the Eurasian swine lineage (Dawood, Jain et al. 2009; Garten, Davis et 
al. 2009; Trifonov, Khiabanian et al. 2009; Zimmer and Burke 2009). This virus was 
first identified in two Californian children in April 2009  (MMWR 2009) and rap-
idly spread to many countries. On June 11, 2009, the Director-General of WHO, Dr. 
Margaret Chan, declared the beginning of the 2009 influenza pandemic 
(http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20
090611/en/index.html) (accessed November 8, 2012). August 10, 2010, again, 
Dr. Chan informed that the world is no longer in phase 6 of influenza pandemic 
alert. In other words, the pandemic was over  
http://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/ind
ex.html). During the pandemic, approximately 18,500 laboratory-confirmed deaths 
caused by the pandemic virus were reported to WHO. However, this seems to repre-
sent only the tip of the iceberg, as later estimates based on modeling studies indicate 
that the mortality rate may have been at least 15-times higher (Dawood, Iuliano et al. 
2012). 
Influenza A(H5N1). In May 1997, a 3-year-old child in Hong Kong died of mul-
tiple complications during an acute respiratory illness. An influenza A virus was 
isolated from a tracheal aspirate collected from the patient 10 days after the onset of 
symptoms (MMWR 1997(a)). The virus was sent to reference laboratories for fur-
ther characterization and it was identified to be an influenza A virus of subtype 
H5N1 (Claas, Osterhaus et al. 1998; Subbarao, Klimov et al. 1998; Yuen, Chan et al. 
1998). Before this incidence, the subtype H5N1 of influenza A virus has never been 
isolated from humans. At the same time, a major outbreak of avian influenza caused 
by this highly pathogenic H5N1 virus was observed in the Hong Kong area. Several 
more individuals contracted infection with this virus later during the same year 
(MMWR 1997(b)). Swift stamping out measures brought the outbreak in birds to a 
halt and no further human cases were observed for several years. However, in early 
2003 the same virus re-emerged in the Hong Kong area (Peiris, Yu et al. 2004) and 
subsequently spread to other countries (Hien, de Jong et al. 2004). This set off a 
world-wide public health response as, under the leadership of WHO and other orga-
nizations, countries started to prepare for a pandemic possibly caused by this virus. 
Until March 31, 2013, this virus caused 622 laboratory-confirmed human cases in 
Azerbaijan, Bangladesh, Cambodia, China, Djibouti, Egypt, Indonesia, Iraq, Lao 
People’s Democratic Republic, Myanmar, Nigeria, Pakistan, Thailand, Turkey, 
and Viet Nam. Overall, 371 (60 %) of these cases have been fatal. 
(www.who.int/influenza/human_animal_interface/EN_GIP_20130312CumulativeN
umberH5N1cases.pdf). Luckily this virus has not yet acquired the ability to easily 
spread from human to human. However, in animal experiments, it has been recently 
shown that a few mutations in several genes can render the virus more transmissible 
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between ferrets, an animal frequently used for studies on human influenza (Herfst, 
Schrauwen et al. 2012; Imai, Watanabe et al. 2012).  
Influenza A(H7N7). In 2003, another highly pathogenic avian influenza virus, 
influenza A(H7N7), caused a massive outbreak in chicken breeding farms of The 
Netherlands. It has been estimated that more than 4,000 individuals have been in-
volved in culling infected birds, cleaning and disinfecting breeding facilities and 
other activities. The H7N7 virus has been detected from 86 of those persons. One of 
them, a veterinarian examining ill animals, died from this infection, all others expe-
rienced relatively mild respiratory symptoms or conjunctivitis. In a few cases, the 
virus was transmitted from poultry workers to their family members (Fouchier, 
Schneeberger et al. 2004; Koopmans, Wilbrink et al. 2004).  
 Influenza A (H9N2, H10N7). In rare instances also other subtypes of influenza A 
have been transmitted to humans. Influenza A(H9N2) is widespread in Asian poultry. 
Two human cases have been described in Hong Kong in 1999 (Peiris, Yuen et al. 1999). 
A few human cases with an influenza A(H10N7) virus have been reported from Egypt 
(http://new.paho.org/hq/dmdocuments/2010/Avian_Influenza_Egypt_070503.pdf) and 
from Australia (Arzey, Kirkland et al. 2012). 
Influenza A(H17). As an interesting curiosity, evidence for an infection with an 
influenza virus has recently been found in bats sampled in Guatemala. The hemag-
glutinin of these viruses is distinct from the 16 subtypes identified so far and it has 
been designated as H17 (Tong, Li et al. 2012). It is speculated that this virus might 
be a precursor of the current influenza A viruses. 
Hantavirus pulmonary syndrome, Sin nombre virus. During the first months 
of 1993, several patients with an influenza-like illness which rapidly progressed to 
respiratory failure were seen in the Four Corners area of New Mexico, Arizona, 
Colorado and Utah (MMWR 1993; MMWR 2010). Based on the clinical picture, 24 
cases, including 12 deaths, were reported by the first week of June, and some of the 
cases have been closely related, even living in the same household, which indicated 
an infectious cause. All laboratory tests for known respiratory pathogens yielded 
negative results (Duchin, Koster et al. 1994). Serologic testing of a wide range of 
pathogens suggested a possible involvement of a hantavirus. Based on this finding it 
was possible to amplify hantavirus specific gene fragments by PCR from tissue 
specimens obtained from patients and from deer mice (Peromyscus maniculatus) 
that were trapped in the area, and the entire nucleotide sequence of the virus could 
be established. It turned out that this illness was caused by a new hantavirus, and the 
sequences obtained from patients and from animals were identical (Nichol, Spiro-
poulou et al. 1993). The illness was named hantavirus pulmonary syndrome (HPS). 
In summer 2012, 6 cases of HPS were identified among the visitors of the Yosemite 
National Park in California. Two of these individuals died (Rhee, Clark et al. 2012; 
WER 2012).  
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Rhinovirus C. During the influenza season 2004 – 2005, laboratories in New 
York received a number of clinical samples from patients with influenza-like illness, 
which remained negative when tested for influenza and other respiratory viruses. 
Applying MassTag PCR technology, a significant fraction of these previously nega-
tive specimens was found to contain rhinoviruses. From these rhinovirus-positive 
samples the nucleotide sequence of the PCR-amplified product was determined. 
Phylogenetic analysis revealed that some of these rhinoviruses formed a unique 
clade between the rhinovirus clades A and B (Lamson, Renwick et al. 2006). These 
results thus revealed a new group of rhinoviruses, subsequently termed rhinovirus C 
(Lau, Yip et al. 2007). Using specific PCR methods for this rhinovirus, it was soon 
recognized that this virus was found in many parts of the world (Briese, Renwick et 
al. 2008) and it is able to cause severe respiratory infections particularly in children 
(Renwick, Schweiger et al. 2007; Khetsuriani, Lu et al. 2008; Peltola, Jartti et al. 
2009). Rhinoviruses are commonly found in respiratory secretions and in middle ear 
fluids of children with acute otitis media, and also rhinovirus C was found in such 
specimens (Savolainen-Kopra, Blomqvist et al. 2009). 
Metapneumovirus. Over a period of 20 years, virologists in The Netherlands 
have identified morphological changes in tertiary cultures of monkey kidney cells 
inoculated with human respiratory specimens. With conventional methods and 
available reagents, no cause for this finding could be determined. However, electron 
microscopic examination of supernatants of the cultures revealed the presence of 
paramyxovirus-like particles. When a random PCR amplification was performed, 20 
different bands were identified for the unknown virus, and the nucleotide sequence 
of these amplification products was determined. The sequences found most closely 
resembled those of an avian pneumovirus. With newly designed, specific primers, it 
was possible to obtain the entire genome of this novel virus, which was then named 
human metapneumovirus (van den Hoogen, de Jong et al. 2001). The authors found 
that by age five, virtually all tested individuals had antibodies against this novel 
virus, and concluded that this virus has been a human pathogen for a long period of 
time. Studying retrospectively respiratory specimens collected from patients of all 
age with respiratory tract infections in Canada, hMPV was identified as a pathogen 
(Boivin, Abed et al. 2002). The authors reported that pneumonitis and bronchiolitis 
were frequent diagnoses in hMPV-infected, hospitalized children, while the most 
common diagnoses in elderly subjects were bronchitis and/or bronchospasm and 
pneumonitis. In a prospective study of young and older adults hospitalized for car-
diopulmonary illnesses, 44 of 984 individuals had evidence of infection with hMPV 
(Falsey, Erdman et al. 2003). 
Polyomaviruses KI and WU. In 2007, two groups, one in Sweden (Allander, 
Andreasson et al. 2007) and one in Australia (Gaynor, Nissen et al. 2007) detected 
two previously unknown polyomaviruses in respiratory specimens using sophisti-
cated molecular methods (polyomavirus KI; polyomavirus WU). The clinical rel-
evance of these two viruses remains unclear. One group in Germany has found  
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these viruses in nasopharyngeal aspirates and bronchoalveolar lavage specimens in 3 
of 229 children hospitalized due to an acute respiratory tract infection (Mueller, 
Simon et al. 2009). No other respiratory viruses were detected in these children ex-
cept in one immunocompromized child whose specimen was positive for cytomega-
lovirus, Epstein-Barr virus, and herpesvirus 6. These polyomaviruses have also been 
detected simultaneously with RSV and adenovirus in lower respiratory tract infec-
tion and in older, severely immunosuppressed individuals and some authors believe 
that there is no association between these viruses and respiratory disease (Norja, 
Ubillos et al. 2007).  
Adenovirus 14p1. In March and April 2006 adenovirus serotype 14 belonging to 
the subspecies B2 was first detected at five military training centers in the United 
States (Metzgar, Osuna et al. 2007; MMWR 2010). Retrospective studies indicated 
that this virus has appeared in Oregon in 2005 (Lewis, Schmidt et al. 2009) and soon 
became the predominant circulating adenovirus. Many of the adenovirus 14-infected 
individuals required hospitalization, supplemental oxygen, intensive care treatment, 
and 7 of 38 patients died (Lewis, Schmidt et al. 2009). Outbreaks in US army train-
ing centers have been described (Tate, Bunning et al. 2009). Detailed genetic analy-
sis suggests that this so called adenovirus 14p1 possibly arose through recombina-
tion of the adenovirus type 11 and 14 ancestral strains (Kajon, Lu et al. 2010). 
Bocavirus. In 2005 Allander and colleagues detected a new parvovirus in naso-
pharyngeal aspirates from patients with respiratory tract infection (Allander, Tammi 
et al. 2005). They extracted nucleic acids from concentrated cell-free supernatants of 
these specimens, and after random PCR amplification cloned and sequenced ampli-
fied products. Phylogenetic analysis of the obtained sequences revealed the presence 
of a novel parvovirus, which was named bocavirus. Based on sequence information, 
the authors developed a PCR method specific for bocavirus and found 7 of 378 res-
piratory specimens to be bocavirus positive, all of those were from children and 
infants (Allander, Tammi et al. 2005). It soon became clear that bocavirus is a res-
piratory pathogen especially of young children in many parts of the world (Sloots, 
Whiley et al. 2008). However, bocavirus can also be found in respiratory samples 
collected from asymptomatic children even for prolonged periods, which also ex-
plains the fact that bocavirus is often detected together with other common respira-
tory viruses (Soderlund-Venermo, Lahtinen et al. 2009; Jartti, Jartti et al. 2012). To 
shed more light on the importance of bocaviruses during early life, Meriluoto and 
colleagues studied serial serum samples 
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Table 1. Newly identified respiratory viruses in humans during the recent 20 years 
from 1993 – 2013.  
 lanigirO suriV publication 
MERS-Coronavirus Zaki, van Boheemen, et al. (2012) 
 
HKU1 Woo, Lau, et al. (2005) 
  
NL63 van der Hoek, Pyrc, et al. (2004) 
  
SARS coronavirus Peiris, Lai, et al. (2003) 
Ksiazek, Erdman, et al. (2003) 
 
Influenza A(H7N9) Gao, Cao et al. (2013) 
 
Influenza A, triple reassortant     Shinde, Bridges, et al. (2009) 
 
Influenza A(H1N1)pdm09 MMWR (2009) 
Dawood, Jain et al. (2009) 
 
Influenza A(H5N1) Subbarao, Klimov, et al. (1998) 
 
Influenza A(H7N7) Koopmans, Wilbrink, et al. (2004) 
 
Influenza A(H9N2) Peiris,Yuen, et al. (1999)  
 
Sin nombre Rhee, Clark, et al. (2012). 
 
Rhinovirus Lamson, Renwick, et al. (2006) 
 
Metapneumovirus van den Hoogen, de Jong, et al. (2001) 
 
WU and KI Allander, Andreasson, et al. (2007)  
Gaynor, Nissen et al. (2007) 
 
Adenovirus 14 Kajon, Lu, et al. (2010) 
 
Bocavirus Allander, Tammi, et al. (2005)  
 
 
from 109 children in a cohort that was followed from infancy to an average of 8 
years (Meriluoto, Hedman et al. 2012). Sampling intervals was between 3 and 6 
months. On an average, seroconversion to bocavirus was detected at the age of 2.3 
years. Secondary immune reactions were seen in one third of these children. Based 
on antibody development, it was determined that primary infection was significantly 
associated with respiratory illness and associated complications. Bocavirus was also 
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found in children hospitalized with lower respiratory tract infection and was a fre-
quent cause of wheezing (Deng, Gu et al. 2012). In that study samples were obtained 
from the lower airways, and it was demonstrated that a high viral load was associ-
ated with more severe infection, longer duration of hospitalization and wheezing. 
It seems that of the bocaviruses only HBoV1 is causing respiratory infections, 
the other bocaviruses appear to cause enteric infections. Because HBoV DNA is 
often found in respiratory specimens together with other respiratory viruses, a PCR 
positive finding alone may not be diagnostic. However, if HBoV1 DNA is found in 
the blood as indication of a viremic phase or if the patient has HBoV1-specific IgM 
antibodies and/or shows a seroconversion to this virus, the diagnosis of HBoV1 
infection can be established. 
 
2.2 “Classical” respiratory viruses 
As long as medical observations have been recorded, respiratory infections have 
played an important role. Hippocrates has described epidemics of respiratory ill-
nesses, which may well have been attributed to influenza. However, the concept of 
viruses has been established approximately 120 years ago with the first transmission 
experiments of the tobacco mosaic virus. Subsequently it has become possible to 
study viruses in experimental animals and later also in embryonated hens’ eggs. In 
fact, the first influenza viruses were isolated from pigs and from humans in ferrets in 
the 1930s. A major breakthrough in virology occurred with the development of tis-
sue- and cell culture techniques. Using egg and cell culture isolation, the number of 
recognized and at least partly characterized viruses, including respiratory viruses, 
rapidly increased during the latter half of last century. This led to the detection of 
rhinoviruses, adenoviruses, parainfluenza viruses, RSV, and the “classical” coro-
naviruses OC43 and 229E. Modern virus classification is largely based on genetic 
characteristics (Table 2). Besides these typical respiratory viruses, also other viruses 
can cause respiratory illnesses. One example are the herpesviruses, in particular the 
cytomegalovirus, which can cause severe pneumonia in immunocompromized indi-
viduals. Although beyond the scope of this thesis, it must be mentioned, that bacte-
ria, including Mycoplasma pneumoniae and chlamydia, fungi, and parasites are sig-
nificant causes of respiratory infections, often also with lethal outcome. Also, very 
importantly, tuberculosis continues to be a major global health threat. 
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Table 2. Viruses often associated with respiratory tract infections 
Virusfamily Virus Nucleic acid Special characteristics 
Orthomyxoviruses Influenza A, B, C RNA negative sense,  
segmented 
Hantaviruses Sin nombre virus RNA negative sense,  
segmented 
Paramyxoviruses Parainfluenza 1 - 4 RNA negative sense 
 RSV RNA negative sense 
 Human metapneumo-
virus 
RNA negative sense 
 Measlesvirus RNA negative sense 
Picornaviruses Rhinovirus A - C RNA positive sense 
 Parechovirus RNA positive sense 
 Coxsackievirus A RNA positive sense 
 Coxsackievirus B RNA positive sense 
 Echovirus RNA positive sense 
Coronaviruses Coronavirus OC43 RNA positive sense 
 Coronavirus 
E229E 
RNA positive sense 
 SARS-coronvirus RNA positive sense 
 Coronavirus NL63 RNA positive sense 
 Coronavirus 
HKU1 
RNA positive sense 
 MERS-coronavirus RNA positive sense 
Adenoviruses Human adenovirus 
A - G 
DNA  
Parvoviruses Human bocavirus DNA  
Polyomaviruses KI polyomavirus  DNA  
 WU polyomavirus DNA  
Herpesviruses Cytomegalovirus DNA  
 Herpes simplex 
virus 1 and 2 
DNA  
 Varicella zoster 
virus 
DNA  
 Epstein-Barr virus DNA  
 Human herpes 
virus 6 - 8 
DNA  
For more detailed information about virus taxonomy see: 
www.ictvonline.org/virusTaxonomy.asp 
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2.3 Surveillance of respiratory viruses 
“The purpose of surveillance is to reduce the impact of disease” (John Watson, per-
sonal communication, first meeting of the European Surveillance Network, ECDC, 
Stockholm, 2009). Acute respiratory infections present the most common medical 
condition people of all ages experience worldwide. In sporadically performed health 
surveys, CDC gathers health information through telephone interviews. In that sur-
vey, acute conditions are defined as health problems, which restrict normal activity 
and/or require medical attention, with onset no longer than 3 months before the 
interview and the condition is not otherwise classified as chronic. The collected data 
is presented as acute conditions per 100 persons per year (Table 3.).  
Table 3. Acute conditions per 100 persons per year, USA, 1995. All acute 
conditions and respiratory conditions. (Adapted from 
http://www.cdc.gov/nchs/data/series/sr 10/101991.pdf; accessed 
November 2012).  
Type of 
condition 
All 
ages 
< 5 
years 
5 – 17 
years 
18 – 24 
years 
25 – 44 
years 
45 – 64 
years 
≥ 65 
years 
All acute 
conditions 
174.4 364.4 236.4 158.4 156.9 119.0 103.0 
All  
respiratory 
conditions 
85.2 159.5 122.8 79.7 80.5 57.6 39.0 
Common 
cold 
23.1 53.7 33.0 21.8 18.6 16.1 12.2 
Other 
acute URI 
12.1 29.5 20.6 9.0 9.7 7.3 4.1 
Influenza 41.2 53.6 59.4 43.1 45.2 28.0 14.0 
Acute 
bronchitis 
5.1 12.7 5.1 4.4 4.4 3.2 5.3 
Pneumonia 2.0 *4.4 *2.1 *0.3 *1.4 2.3 *2.2 
Other 
respiratory 
conditions 
1.7 5.5 2.5 *1.1 *1.2 *0.7 *1.2 
* The authors of this study indicate that these numbers do not meet standard of reliability or precision. 
 
According to these numbers, children, particularly young children under five 
years of age, frequently experience respiratory illnesses associated with absence 
from daycare or school and eventually require visits at a health care provider. A 
similar declining number of respiratory infections per year with increasing age 
has been observed in the classical Tecumseh and Michigan studies conducted in 
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the late 1960s and early 1970s as reviewed elsewhere (Monto 2002). In a global 
survey presented by WHO, lower respiratory infections were listed, after 
ischemic heart disease and cerebrovascular disease, as the third leading cause of 
death in 2004, responsible for over 7 percent of all deaths 
http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. 
Furthermore, if the global burden of disease is expressed as “disability adjusted life 
years lost” (DALYs), lung infection ranked as number 1, before HIV/AIDS and 
neoplasms (Mizgerd 2006). In this report, the category “lung infections” includes 
“influenza and pneumonia” (ICD-10 codes J10 – J18) and “other acute lower respi-
ratory tract infections” (ICD-10 codes J20 – J22), but excludes “tuberculosis” and 
“HIV infections resulting in infectious and parasitic diseases”. A more recent study 
supports the concept that respiratory infections are important factors in global health 
and as the cause of life years lost (Lozano, Naghavi et al. 2012). From these statis-
tics it is impossible to estimate in which proportions bacteria and viruses are in-
volved. Ruuskanen and colleagues estimated that approximately 200 million cases 
of community-acquired pneumonia caused by viruses occur every year, half of those 
in children (Ruuskanen, Lahti et al. 2011). In adults, viruses are the predominant 
cause of the common cold (Makela, Puhakka et al. 1998). Using highly sensitive 
molecular methods for the detection of a large variety of respiratory viruses, 92 % of 
children with a recent onset of common cold were found virus positive (Ruohola, 
Waris et al. 2009). These reports underscore the fact that respiratory tract infections, 
including those caused by viruses, present a significant public health problem.  
Understanding the global, regional, and local epidemiology of respiratory patho-
gens, identifying the spectrum of clinical symptoms caused by a given pathogen, 
adequate use of antibiotics and antiviral drugs, monitoring the possible development 
of drug-resistance, prevention of nosocomial spread, update of the seasonal influ-
enza vaccine composition, and rapid identification and characterization of “novel” or 
unusual respiratory pathogens, are some of the reasons why surveillance of respira-
tory pathogens is conducted at the national and international level. 
As one of its first surveillance programs, WHO established a global influenza 
surveillance network, currently named Global Influenza Surveillance and Response 
System (GISRS). At present, this network consists of 140 National Influenza Cen-
ters (NIC) in 110 WHO member states, 6 WHO Collaborating Centers (Atlanta, 
Beijing, London, Melbourne, Memphis, Tokyo) and 4 Essential Regulatory Labora-
tories (Hertfordshire, UK; Rockville, MD; Tokyo, Japan; Woden ACT, Australia). 
The GISRS plays a central role in the influenza vaccine virus selection process 
(Ampofo, Baylor et al. 2012). NICs collect clinical samples from patients with 
influenza-like illnesses (ILI) or acute respiratory infection (ARI), attempt to detect 
influenza and other respiratory viruses in these samples by virus culture or by other 
methods, performing typing, subtyping, and initial genetic and antigenic characteri-
zation of these viruses. NICs send selected virus isolates and/or clinical specimens 
to the regional WHO Collaborating Centers for further analyses. Based on results 
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from these analyses and on information on the geographical spread of these viruses 
and their impact, a group of experts under the co-ordination of WHO Headquarters 
makes recommendations as to what viruses should be included in influenza vaccines. 
Selected viruses are made available to Essential Regulatory Laboratories, which 
prepare high growth reassortant viruses that then are distributed to vaccine manufac-
turers. Since 1973 WHO has made formal recommendations for the vaccine compo-
sition (Klimov, Garten et al. 2012), until 1977 for influenza A(H3N2) and influenza 
B viruses, and since the re-emergence of influenza A(H1N1) viruses in 1977 (Kung, 
Jen et al. 1978) also a vaccine virus for this subtype has been included in the rec-
ommendations. Table 4 presents WHO recommended influenza vaccine strains for 
seasonal and pandemic vaccines. This list, spanning over 40 years, contains 10 dif-
ferent influenza A(H1N1) viruses, 24 influenza A(H3N2) viruses, and 15 influenza 
B viruses. Another important role of GISRS is to rapidly identify unusual subtypes 
of influenza A viruses from zoonotic transmissions. For the surveillance of animal 
influenza viruses, WHO is in close cooperation with the World Organization for 
Animal Health (OIE) and the UN Food and Agriculture Organization (FAO) 
(http://www.offlu.net/). A number of national and international surveillance systems 
have been established in addition to the WHO network (Fleming, van der Velden et 
al. 2003; Fleming and Elliot 2008). As an example, the European Influenza Surveil-
lance Scheme (EISS) has started to compile surveillance data from 7 European 
countries in 1995 (Snacken, Manuguerra et al. 1998). In 2008, this surveillance net-
work was integrated into the activities of the European Center for Disease preven-
tion and Control (ECDC) in Stockholm. Influenza surveillance in Europe has shed 
light on influenza activity during a number of influenza seasons (Paget, Marquet et 
al. 2007). The Community Network of Reference Laboratories (CNRL) has pro-
vided laboratory data on influenza virus detections (Meijer, Valette et al. 2005; Mei-
jer, Brown et al. 2006). This network also provides virological data on the occur-
rence of RSV in Europe (Meerhoff, Mosnier et al. 2009). 
An important task of laboratory-based influenza surveillance is to test circulating 
influenza viruses for their susceptibility to antiviral drugs. When the adamantanes 
amantadine and rimantadine more widely came into clinical use, within a few years 
virtually all human influenza A viruses became resistant to these two compounds 
(Ziegler, Hemphill et al. 1999; Bright, Medina et al. 2005). In influenza A(H1N1) 
viruses circulating in Europe during the 2007 – 2008 season, resistance to the 
neuraminidase inhibitor oseltamivir emerged 
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Table 4. Influenza virus strains recommended by WHO to be included in seasonal 
influenza vaccines 1973 – 2013 for the Northern Hemisphere and for the 
pandemic vaccine 2009. 
Season Influenza A (H1N1) Influenza A (H3N2) Influenza B 
1973/74  A/England/42/721  
1974/75  A/Port Chalmers/1/19732 B/Hong Kong/05/1972 
1975/76  A/Scotland/840/74 B/Hong Kong/05/1972 
1976/77  A/Victoria/3/75 B/Hong Kong/05/1972 
1977/78  A/Victoria/3/75 B/Hong Kong/05/1972 
1978/99 A/USSR/90/77 A/Texas/1/77 B/Hong Kong/05/1972 
1979/80 A/USSR/90/77 A/Texas/1/77 B/Hong Kong/05/1972 
1980/81 A/Brazil/11/78 A/Bangkok/01/79 B/Singapore/222/79 
1981/82 A/Brazil/11/78 A/Bagkok/01/79 B/Singapore/222/79 
1982/83 A/Brazil/11/78 A/Bangkok/01/79 B/Singapore/222/79 
1983/84 A/Brazil/11/78 A/Philippines/2/82 B/Singapore/222/79 
1984/85 A/Chile/1/83 A/Philippines/2/82 B/USSR/100/83 
1985/86 A/Chile/1/83 A/Philippines/2/82 B/USSR/100/83 
1986/87 A/Chile/1/83 A/Christchurch/4/85 B/Ann Arbor/1/86 
1987/88 A/Singapore/6/86 A/Leningrad/360/86 B/Ann Arbor/1/86 
1988/89 A/Singapore/6/86 A/Sichuan/02/87 B/Beijing/1/87 
1989/90 A/Singapore/6/86 A/Shanghai/11/87 B/Yamagata/16/88 
1990/91 A/Singapore/6/86 A/Guizhou/54/89 B/Yamagata/16/88 
1991/92 A/Singapore/6/86 A/Beijing/353/89 B/Yamagata/16/88 
1992/93 A/Singapore/6/86 A/Beijing/353/89 B/Yamagata/16/88 
1993/94 A/Singapore/6/86 A/Beijing/32/92 B/Panama/45/90 
1994/95 A/Singapore/6/86 A/Shangdong/9/93 B/Panama/45/90 
1995/96 A/Singapore/6/86 A/Johannesburg/33/94 B/Beijing/184/93 
1996/97 A/Singapore/6/86 A/Wuhan/359/94 B/Beijing/184/93 
1997/98 A/Bayern/7/95 A/Wuhan/359/94 B/Beijing/184/93 
1998/99 A/Beijing/262/95 A/Sydney/5/97 B/Beijing/184/93 
1999/00 A/Beijing/262/95 A/Sydney/5/97 B/Beijing/184/93 
2000/01 A/New Caledonia/20/99 A/Moscow/10/99 B/Beijing/184/93 
2001/02 A/New Caledonia/20/99 A/Moscow/10/99 B/Sichuan/379/99 
2002/03 A/New Caledonia/20/99 A/Moscow/10/99 B/Hong Kong/330/2001 
2003/04 A/New Caledonia/20/99 A/Moscow/10/99 B/Hong Kong/330/2001 
2004/05 A/New Caledonia/20/99 A/Fujian/411/2002 B/Shanghai/361/2002 
2005/06 A/New Caledonia/20/99 A/California/7/2004 B/Shanghai/361/2002 
2006/07 A/New Caledonia/20/99 A/Wisconsin/67/2005 B/Malaysia/2506/2002 
2007/08 A/Solomon Islands/3/2006 A/Wisconsin/67/2005 B/Malaysia/2506/2002 
2008/09 A/Brisbane/59/2007 A/Brisbane/10/2007 B/Florida/4/2006 
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2009 A/California/7/20093   
2009/10 A/Brisbane/59/2007 A/Brisbane/10/2007 B/Brisbane/60/2008 
2010/11 A/California/7/2009 A/Perth/16/2009 B/Brisbane/60/2008 
2011/12 A/California/7/2009 A/Perth/16/2009 B/Brisbane/60/2008 
2012/13 A/California/7/2009 A/Victoria/361/2011 B/Wisconsin/1/2010 
2013/14 A/California/7/2009 A/Victoria/361/2011 B/Massachusetts/2/2012 
1The A/England/42/72(H3N2) has been included in seasonal vaccines prior to 1973, but at that time, the rec-
ommendations have not yet been done by WHO. 
2Virus strains in bold font present a change of virus strain in that season’s vaccine. 
3The vaccines produced for the 2009 pandemic contained only the A(H1N1)pdm09 virus. 
 
(Lackenby, Hungnes et al. 2008; Meijer, Lackenby et al. 2009), and quickly spread 
around the globe (Moscona 2009)  
http://www.who.int/influenza/patient_care/antivirals/oseltamivir_summary_south_2008/en/. 
Clinical diagnosis of respiratory infections. Based on the clinical picture alone 
it is rarely possible to specifically identify the causing agent of a respiratory infec-
tion. A large study aimed to identify the most predictive signs and symptoms for 
influenza in patients with influenza-like illness (Monto, Gravenstein et al. 2000). 
Patients presenting with cough and fever were most likely to experience a labora-
tory-confirmed influenza infection with a positive predictive value of 79 %. In an-
other study, patients with influenza-like symptoms were recruited to determine the 
efficacy of treatment with zanamivir (Makela, Pauksens et al. 2000). In this investi-
gation, 277 of 356 patients (78 %) were found influenza-positive by laboratory test-
ing. Both studies have been conducted with adolescent or adult, otherwise healthy 
individuals. In a study of 683 hospitalized children with laboratory-confirmed influ-
enza A or B infection it was shown that the clinical presentation in young children is 
less specific than in older children and adults, and therefore laboratory diagnosis is 
often justified (Peltola, Ziegler et al. 2003). 
 
2.4 Laboratory diagnosis of respiratory tract infections 
2.4.1 Patients and specimens 
Over the course of respiratory tract infections the amount of pathogen present in 
respiratory tract secretions diminishes. Viruses can be present before clinical symp-
toms occur. During the first days of the acute illness the amount of virus reaches its 
maximum and thereafter diminishes over the course of a few days. For that reason it 
is important to collect samples for the detection of viruses by culture, by antigen 
detection, or by detection of nucleic acids early during the clinical illness (Ronkko, 
Ikonen et al. 2011). For serodiagnosis of respiratory infection, the first serum sample 
should be drawn early during the acute phase and the convalescent phase sample 2 
to 4 weeks later. 
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Specimens suitable for the detection of respiratory tract pathogens include naso-
pharyngeal aspirates, nasopharyngeal and/or throat swabs (Gnarpe, Lundback et al. 
1997; Heikkinen, Salmi et al. 2001; Waring, Halse et al. 2001; Meerhoff, Houben et 
al. 2010) nasopharyngeal washes (Berg, Yolken et al. 1980), sputum (van Kup-
peveld, Johansson et al. 1994), and, in special cases, specimens that require more 
invasive sampling methods such as middle ear fluids, tracheal aspirates, pleural fluid 
specimens, bronchoalveolar lavage specimens, transthoracic needle aspirates, and 
autopsy specimens. Although not a very pleasant method, nasopharyngeal aspirates 
have proven to be an excellent clinical sample for the detection of respiratory vi-
ruses by several methods including antigen detection by immunofluorescent anti-
body staining or by immunoassays, by culture, and by molecular methods. Nasopha-
ryngeal aspirates appear to contain large numbers of exfoliated, epithelial cells, 
some of which may contain virus antigens. During recent years, a flocked swab has 
found wide application. This swab is manufactured such that it traps epithelial cells 
between the brushes and efficiently releases them into either a transport medium or 
an extraction buffer (Abu-Diab, Azzeh et al. 2008; Faden 2010; Ampofo, Baylor et 
al. 2012). 
2.4.2 Development of diagnostic methods 
Based on patient’s clinical symptoms, it is difficult or impossible to identify the 
causing agent because infections with many different respiratory pathogens can 
present with the same symptoms. The traditional methods for the diagnosis of res-
piratory virus infections are virus culture and serology performed on acute and con-
valescent-phase sera (Monto and Kioumehr 1975). With these methods, only in rare 
instances was it possible to obtain a result as long as it would have been of any ben-
efit for the patient or for the treating physician. When the antiviral drug amantadine 
came in clinical use, and particularly when the risk of nosocomial infections in the 
hospital environment was better understood, the need for more rapid diagnostic 
methods became evident.  
Four main categories of methods are available for diagnosing infections caused 
by respiratory viruses and Mycoplasma pneumoniae. These include viral and bacte-
rial culture, detection of microbial antigens with immunological methods, amplifica-
tion of nucleic acids, and serology. 
2.4.2.1 Antigen detection methods 
Time-resolved fluoroimmunoassay (TR-FIA). The TR-FIA technology was de-
veloped in the 80’ies in the Wallac Research Laboratories (Turku, Finland). The 
principles of the technology were described by Soini and Kojola 1983 (Soini and 
Kojola 1983) and Hemmilä et al. (Hemmila, Dakubu et al. 1984). This method al-
lows for the specific identification of proteins with high sensitivity and within a 
short time. This method was soon adapted for the rapid detection of common res-
piratory viruses in clinical samples obtained from patients with upper and lower 
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respiratory tract infections (Halonen, Meurman et al. 1983). Specimen preparation 
before testing is simple, i.e., it does not require isolation of infected cells from naso-
pharyngeal secretions as necessary for fluorescent antibody staining. Usually the 
sample is eluted or diluted in a detergent-containing buffer and then homogenized 
by ultrasonic treatment.  
The method for detection of influenza infections by TR-FIA using monoclonal 
antibodies as immunoreagents was first published by Walls and colleagues (Walls, 
Johansson et al. 1986). One year later Hierholzer and colleagues described a similar, 
slightly refined TR-FIA method for the detection of adenovirus antigens in respira-
tory secretions and in stool specimens (Hierholzer, Johansson et al. 1987). This so-
called ”one-incubation method” was then also adapted for the detection of influenza 
A and B viruses (Nikkari, Halonen et al. 1989), of RSV (Waris, Halonen et al. 
1988), and of parainfluenza virus, types 1 – 3 (Hierholzer, Bingham et al. 1989). In 
some of these investigations, the sensitivity of TR-FIA methods was comparable to 
that of previously used EIA and RIA tests using polyclonal antisera as immuno-
reagents. TR-FIA was found to be more sensitive and also more specific than the 
older immunoassays. A thorough, systematic comparison against virus culture, 
which was at that time regarded as the ”golden standard”, has never been performed. 
However, TR-FIA with one short incubation time proved to be a useful assay for the 
simultaneous detection of several viruses and is well suited for routine diagnosis of 
respiratory viral infections in a diagnostic laboratory. Equivocal results can be con-
firmed by a control test adding an incubation step with the unlabeled virus-specific 
antibody before adding the Eu-conjugated antibody. 
This TR-FIA method for the detection of seven common respiratory viruses was 
used in several clinical and epidemiological studies (Ruuskanen, Arola et al. 1989; 
Arola, Ziegler et al. 1990; Mertsola, Ziegler et al. 1991; Waris, Meurman et al. 
1992; Makela, Puhakka et al. 1998).  
In order to make this technique more widely available to laboratories without 
TR-FIA equipment, Scalia et al. (Scalia, Halonen et al. 1995) biotinylated the same 
monoclonal antibodies as used in TR-FIA studies. Biotin labeling allowed the use of 
peroxidase-labeled streptavidin conjugates and widely available EIA spectropho-
tometers. In that study, the EIA format turned out to be less sensitive than the cor-
responding TR-FIA method. 
Methods for virus antigen detection still are widely used in diagnostic laborato-
ries, but during recent years they have to some extent been replaced by PCR. 
Immunofluorescent antibody staining (IF). The first practical technique that 
became available for the rapid diagnosis of respiratory tract infections was fluores-
cent antibody staining of virus-infected epithelial cells. This technique was devel-
oped and refined in the 1960s. Several technical problems had to be overcome in 
order to make this method reliable for laboratory diagnosis. One of the major prob-
lems was the specificity of the immunoreagents. Initially high-titered human sera 
were used, later animal hyperimmune sera, and nowadays mouse monoclonal anti-
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bodies are the standard. Additional problems were the specimen transport and prepa-
ration. Several methods for the purification of virus-infected, exfoliated epithelial 
cells have been described to free the cells from the contaminating mucus (Ukkonen 
and Julkunen 1987). Combining these purification methods with highly specific, 
commercially available monoclonal antibodies significantly improved the reliability 
of this technique and it is still used in many diagnostic laboratories (Shen, Zhaori et 
al. 1996). Reading of samples can be influenced by non-specific staining, and the 
quality of the test result always depends on the interpretation of the microscopist. On 
the other hand, an experienced microscopist may find a single infected cell on a 
stained slide, which renders this technique highly sensitive.  
IF techniques have been used lately alongside with molecular methods in the 
search for the emerging viruses of this century (Yuen, Chan et al. 1998; van der 
Hoek, Pyrc et al. 2004; Zaki, van Boheemen et al. 2012). 
Solid-phase immunoassays. The direct detection of viral antigens in clinical 
specimens has first been accomplished for the Australia antigen of hepatitis B virus 
using radioimmunoassay technology (Walsh, Yalow et al. 1970). RIA has been 
widely applied in the laboratory diagnosis of respiratory virus infections (Sarkkinen, 
Halonen et al. 1981). The availability of enzyme-labeled conjugates has simplified 
the further development of solid-phase immunoassays for laboratory diagnostic 
purposes (Berg, Yolken et al. 1980). RIA and EIA have been found to be of equal 
sensitivity. A comparative study of the sensitivity of RIA and EIA for the detection 
of RSV, parainfluenza virus type 2, and adenovirus in NPAs of children showed that 
both methods were able to detect between 1 and 30 ng of virus protein per ml 
(Sarkkinen, Halonen et al. 1981). In another study, RIA was used for direct detec-
tion of viral antigens in nasopharyngeal secretions and results were compared with 
serology carried out by EIA (Meurman, Sarkkinen et al. 1984). Large numbers of 
specimens can be processed using RIA or EIA. With the numeric output of results 
by RIA, EIA, and other similar immunoassays, subjective interpretation of results as 
often observed by IF could be excluded. 
Rapid point-of-care tests can be completed within 15 – 30 minutes without any 
special equipment and can therefore be performed in a doctor’s office, in an outpa-
tient clinic or a hospital ward. These so called “point-of-care” tests have been in 
clinical use for over 20 years for the detection of influenza viruses and RSV 
(Rothbarth, Hermus et al. 1991; Waner, Todd et al. 1991; Ryan-Poirier, Katz et al. 
1992). The diagnostic sensitivity and reliability of such rapid tests remains to be a 
topic of discussion (MMWR 2012)    (www.cdc.gov/mmwr/pdf/wk/mm6143.pdf). 
The further development and refinement of the TR-FIA method lead to the invention 
of a two-photon excitation fluorometry technique. This method has been success-
fully applied for the detection of respiratory pathogens in clinical specimens 
(Koskinen, Vainionpaa et al. 2007). It is highly specific and sensitive, and positive 
results can be obtained within a few minutes. However, this method requires sophis-
ticated equipment.  
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2.4.2.2 Virus culture  
Traditional cell culture. Many human respiratory viruses can be propagated in cell 
cultures or in hen’s eggs. Virus culture continues to play an important role, because 
it provides an infectious virus for further characterization and thus is complementary 
to rapid and molecular methods. Virus culture is also important in the identification 
of previously unknown viruses, such as hMPV (van den Hoogen, de Jong et al. 
2001), SARS coronavirus (Peiris, Yuen et al. 2003), and MERS-coronavirus (Zaki, 
van Boheemen et al. 2012). When presumably dealing with previously unknown 
viruses, a variety of cell lines must be inoculated with a clinical specimen in order to 
increase chances that the virus will grow at least in one of these cell lines (van der 
Hoek, Pyrc et al. 2004; Zaki, van Boheemen et al. 2012). 
In many respiratory tract infections, patients shed virus only during a short pe-
riod, sometimes already before the onset of symptoms, and usually ceases within a 
few days. Specimens for virus culture must therefore be collected at an early stage 
of the illness. It often takes time to get the virus adapted to grow in a certain cell line 
and eventually one or more blind passages need to be performed to obtain an isolate. 
Virus type and subtype can be identified by immunological methods using hy-
perimmune sera or monoclonal antibodies (Pyhala and Pyhala 1987; Harmon 1992) 
or by molecular methods. 
Rapid culture of viruses. Rapid culture of viruses allows for the identification 
of a virus in cell culture using immunofluorescent or immunoperoxidase staining 
methods before a virus-induced cytopathic effect can be microscopically identified. 
Rapid culture is commonly performed in shell vials or in multi-cluster dishes (Espy, 
Smith et al. 1986; Espy, Hierholzer et al. 1987; Trabelsi, Pozzetto et al. 1992). As 
early as 18 hours after inoculation, virus replication in infected cells can be visual-
ized after immunostaining (McQuillin, Madeley et al. 1985; Routledge, McQuillin et 
al. 1985; Waris, Ziegler et al. 1990; Ziegler, Hall et al. 1995). The sensitivity of 
rapid culture methods is comparable to that of standard virus culture, and the result 
is often available in due time to be helpful in the management of the patient. 
2.4.2.3 Serology 
Complement fixation test (CFT). The principles of complement fixation test (CFT) 
were adapted from Hawkes (Hawkes 1979), and Casey (Casey 1965). Most reliable 
results are obtained when acute- and convalescent-phase sera are tested simulta-
neously with a demonstration of a significant titer rise. In certain cases, a high titer 
obtained from a single serum by CFT may be indicative of recent infection. Optimal 
timing and interval of serum collection has been studied for influenza by Pyhälä and 
Kleemola (Pyhala and Kleemola 1976) and was determined to be between 3 and 4 
weeks. 
Hemagglutination inhibition (HI test). The standard HI test can be used for vi-
ruses that can agglutinate erythrocytes (Hierholzer, Suggs et al. 1969). HI tests are 
widely used for the serodiagnosis of influenza infections and for the monitoring of 
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the efficacy of influenza vaccinations (Pyhala, Kleemola et al. 1985; Pyhala, Ikonen 
et al. 2001; Strengell, Ikonen et al. 2011). Antibodies against the viral hemagglutinin 
HA, measured by the HI test, presumably protect from influenza infection with a 
homologous virus (Kojimahara, Maeda et al. 2006). 
Neutralization test. Neutralization has been widely used for typing of viruses 
but can be used for the measurement of specific antibodies as well (Ludwig, 
Brundage et al. 1998; Lehtoranta, Villberg et al. 2009). 
Solid-phase enzyme immunoassays (EIA). The specificity of solid-phase im-
munoassys depends largely on the specificity of the antigens used (Engvall, Jonsson 
et al. 1971; Engvall and Perlmann 1971; Van Weemen and Schuurs 1971; McIntosh, 
Wilfert et al. 1978; Voller, Bartlett et al. 1978). There are studies showing that EIA 
detected considerably more diagnostic titer rises than CFT between acute and conva-
lescent sera when antibodies against influenza A and B viruses, parainfluenza vi-
ruses, and adenoviruses were measured by both methods and the results were com-
pared with each other (Meurman, Ruuskanen et al. 1984; Julkunen, Pyhala et al. 
1985).  
Antibodies of the IgM class are normally produced in an immunocompetent in-
dividual during the first contact with a certain pathogen. In terms of respiratory vi-
ruses, this usually happens in children and young adults who have not earlier been 
infected with the specific or a closely related pathogen. Assays for the detection of 
IgM-class antibodies can usually be performed with a single serum sample taken 
early during the course of an infection (Hirschberg, Krook et al. 1988; Vikerfors, 
Grandien et al. 1988).  
Among adolescents, adults, and the elderly with respiratory infections, the ap-
pearence of IgM antibodies is inconsistent, partly because the majority of these in-
fections are re-infections (Makela, Nikkari et al. 1995). In contrast, also in reinfec-
tions, IgG class antibodies usually rise significantly, and a four-fold increase in anti-
body titers between acute- and convalescent-phase sera can in many cases be dem-
onstrated as proof of recent infection. 
Distinction between acute infection and pre-existing immunity by avidity 
testing of antibodies. The presence of IgG class antibodies in a single serum sample 
does not reveal whether these antibodies are indicative of an acute or very recent 
infection or whether they are derived from an infection with the same pathogen in 
the past. After primary infection with a pathogen, the avidity of pathogen-specific 
IgG class antibodies maturates over a period of weeks or months. With special 
methods, the degree of an antibody’s avidity can be identified and thus an acute 
infection can be differentiated from an infection in the past. This method has been 
developed in the late 1980s for differentiation between acute and re-infection with 
rubella virus (Hedman and Seppala 1988; Rousseau and Hedman 1988) and has 
since been applied for many different pathogens. (Smolander, Koskinen et al. 2010; 
Freitas, Silva et al. 2011).  
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2.4.2.4 Molecular methods 
The availability of a thermostable DNA polymerase, i.e., the Taq-polymerase op-
ened the way for the polymerase chain reaction (PCR) method into the diagnostic 
laboratory in the late 1980s. Saiki and colleagues (Saiki, Gelfand et al. 1988) first 
published the PCR format that basically still forms the principle for all the refined 
methods that have been developed and introduced thereafter. In virology, the 
method was first applied for the detection of DNA viruses, but soon the method 
could also be applied for RNA viruses when high quality reverse transcriptase en-
zymes became available commercially.  
Isolation of M. pneumoniae requires a complex growth medium and it may take 
several weeks to obtain a positive result. Therefore, PCR greatly improved the 
possibility to detect this pathogen in clinical specimens, and it was one of the first 
microbes that could be detected by PCR (Bernet, Garret et al. 1989; Jensen, Sonder-
gard-Andersen et al. 1989). The first publications on adenovirus PCR appeared in 
1990 (Allard, Girones et al. 1990). The PCR technique and its modifications helped 
in the identification of viruses for which no susceptible cell lines or other detection 
systems are available. Picornaviruses were the first RNA viruses that could be de-
tected and identified by RT-PCR  (Hyypia, Auvinen et al. 1989). PCR was also ap-
plied for the detection of pathogens for which no susceptible cell lines or other isola-
tion systems are available. An illustrative example are the bocaviruses (Allander, 
Tammi et al. 2005). Also for viruses that can be grown in cell cultures, PCR was 
found to be a considerably more sensitive method. In a careful comparison of rhino-
virus culture in HeLa Ohio cells and RT-PCR, Mäkelä and colleagues detected 103 
rhinovirus-positive specimens by PCR but only 80 by culture (Makela, Puhakka et al. 
1998). Due to their antigenic diversity, for certain virus families it would also be 
difficult to prepare suitable reagents to be used in immunoassays (Wong, Pabbaraju 
et al. 2009) and therefore PCR is a practical method for the detection of such viruses. 
Bioinformatics assists in the identification of conserved gene sequences among 
viruses belonging to the same family. Using this information it was possible to de-
velop PCR methods that widely detect members of rhinoviruses (Nokso-Koivisto, 
Raty et al. 2004), of the paramyxovirus family (van Boheemen, Bestebroer et al. 
2012), or coronaviruses (Moes, Vijgen et al. 2005). This pancoronavirus PCR 
greatly assisted in the recent identification of the MERS-coronavirus in summer 
2012 (Zaki, van Boheemen et al. 2012). 
An important improvement of the PCR technology is the possibility to combine 
reagents for the detection of different pathogens in one reaction, i.e., multiplex PCR. 
This development considerably contributed to the wider availability of the technol-
ogy in diagnostic laboratories because multiplex PCR helps saving costs for reagents. 
Multiplex PCR methods have been widely applied for the detection of respiratory 
viruses in clinical samples (Templeton, Scheltinga et al. 2004; Ronkko, Ikonen et al. 
2011). Assays for the detection of up to 16 different respiratory pathogens are 
nowadays available from commercial sources. 
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As with any laboratory technique, also for PCR methods the quality of the clini-
cal specimen is of utmost importance. Viruses and their nucleic acids start disap-
pearing from respiratory secretions only a few days after onset of diseases, often 
already during the acute phase of the illness (Ronkko, Ikonen et al. 2011). However, 
if respiratory samples are collected from children presenting early with symptoms of 
the common cold, with the aid of PCR technology an etiologic agent can be identi-
fied for almost all patients (Ruohola, Waris et al. 2009). Using highly sensitive 
methods, it is not unusual to detect more than one pathogen in a clinical specimen. 
Also in the study by Ruohola and colleagues, 25 percent of the study patients har-
bored two, three, or even four respiratory viruses simultaneously. In these cases, it is 
difficult to determine which of the viruses is the true causing agent. Quantitative 
PCR and/or serological methods may help in finding answers to this question. Based 
on results from quantitative PCR, the viruses showing the lowest Ct value might be 
the one that is acutely replicating and thus causing the symptoms. A diagnostic titer 
rise or the presence of virus-specific IgM antibodies may further help determining 
which of the viruses causes the current illness (Don, Soderlund-Venermo et al. 
2011).  
Although PCR is a highly sensitive, flexible and powerful diagnostic method, for 
the time being it does not completely replace virus culture and other commonly used 
diagnostic methods. Virus isolates are still required for the selection of vaccine vi-
ruses and for the determination of antiviral drug susceptibility.  
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3 Aims of the Study 
The aim of the present thesis work was to develop and validate laboratory methods 
for the detection of seven common respiratory viruses and of Mycoplasma pneumo-
niae and to apply these methods on clinical specimens collected for different pur-
poses. 
The specific aims were: 
1. To determine the diagnostic sensitivities and specificities of virus culture 
techniques, antigen detection by TR-FIA, gene amplification by PCR and 
CFT serology for the identification of adenovirus infections in military re-
cruits 
2. To clarify the role of M. pneumoniae in acute otitis media.  
3. To evaluate the best suited type of clinical specimens for the detection of 
M. pneumoniae  
4. To demonstrate the value of serology in the diagnosis of infections caused 
by seven common respiratory viruses and M. pneumoniae. 
5. To study the epidemiology of adenoviruses, influenza A and B viruses, 
parainfluenza viruses type 1, 2, and 3, RSV and M. pneumoniae based on 
clinical specimens collected from patients with acute respiratory infections 
representing several population groups over a period of 16 years from 
1989 to 2005. 
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4 Patients, Clinical Specimens, 
and Laboratory Methods 
Respiratory specimens and paired serum samples have been collected from indi-
viduals presenting with symptoms of an ongoing respiratory infection. Participating 
doctors and medical centers were requested to take respiratory and acute-phase 
serum samples as early as possible during the course of illness, preferably within 1 – 
3 days. Convalescent-phase sera were usually taken 2 – 4 weeks later. Testing of 
clinical specimens was provided to the treating physician as a primary diagnostic 
service. Specimens were collected in order to aid clinicians in their decisions on 
treatment of the patient or on the design of counter-measures to limit the epidemic, 
e.g., in military training centers. The number of patients and specimens collected, as 
well as the methods used in each study, is presented in Table 5.  
Table 5. Patient groups included in these studies, and specimens collected 
Publication Patients Number of  
infection 
episodes 
Type of specimens 
collected 
Methods used 
I Military recruits 
with ARI 
269 NPA, acute and con-
valescent sera 
TR-FIA, PCR, 
culture, CFT 
II Children with 
AOM 
138 NPA, MEF, acute and 
convalescent sera 
TR-FIA, PCR,  
CFT  EIA 
III Children with 
AOM 
447 NPA, MEF, acute and 
convalescent sera 
TR-FIA, CFT,  
EIA 
IV Military recruits 
with X-ray  
confirmed 
pneumonia 
32 NPA, TS, sputum, 
acute and convales-
cent sera 
PCR, CFT 
This thesis Civil and military 
patients of all 
age groups with 
ARI 
12,020 NPA, acute and con-
valescent sera 
TR-FIA, CFT 
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4.1 Evaluation of laboratory methods for the detection of 
adenoviruses (I) 
During an adenovirus outbreak in military training centers between January and 
April, 1991, clinical specimens were collected from 269 patients. NPA specimens 
were studied by rapid and conventional culture in A-549 cells, by PCR, by EIA, and 
by TR-FIA. Acute and convalescent phase serum specimens were tested by adenovi-
rus CFT using an in-house produced antigen prepared from adenovirus type 1 in-
fected, cultured cells. 
 
4.2 The role of M. pneumoniae as a causative agent of AOM in 
children (II) 
The FinOM Cohort Study was conducted from 1994 to 1997 and included 329 chil-
dren with AOM. From 138 children 380 MEF specimens were tested by a PCR 
method specific for the P1 protein gene of M. pneumoniae. Corresponding NPA 
specimens obtained during the same episode were tested by PCR for the presence of 
M. pneumoniae. In 268 episodes, an NPA was collected simultaneously with the 
MEF. For 225 episodes, paired acute and convalescent phase serum specimens were 
tested by CFT as described (I). 
 
4.3 Evaluation of optimal specimens for the detection of M. 
pneumoniae by PCR and by CFT (III) 
Between October 2001 and January 2002, NPA, sputum, throat swab, and acute and 
paired serum specimens were collected from 32 military recruits aged 22 – 29, hos-
pitalized with an X-ray confirmed pneumonia. Detection of M. pneumoniae DNA 
was done by PCR. M. pneumoniae specific antibodies were measured by CFT using 
an in-house prepared antigen extracted from cultured M. pneumoniae bacteria (strain 
ATCC 29342). 
 
4.4 Comparison of serology and antigen detection in the diag-
nosis of AOM in children (IV) 
From 447 episodes experienced by 179 children 2 months to 2 years of age, a com-
plete set of clinical specimens (NPA, MEF, and acute and convalescent sera) was 
available. NPA and MEF specimens were tested for the presence of adenovirus, 
influenza virus types A and B, parainfluenza virus types 1, 2, and 3, and RSV by 
TR-FIA. From acute and convalescent phase sera, antibodies to RSV were measured 
by EIA using a commercial antigen. Antibodies to adenovirus, influenza virus types 
A and B, parainfluenza virus types 1, 2, and 3 were assessed by CFT. 
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4.5 Sixteen years laboratory surveillance of seven common 
respiratory viruses and M. pneumoniae in Finland (this thesis) 
Between September 15, 1989, and June 15, 2005, 12,020 events of acute respiratory 
tract infections (ARI) or influenza-like illnesses (ILI) were analyzed. Specimens 
were collected from different population groups. The types of specimens collected 
were NPA and paired acute and convalescent phase sera. Both types of specimens 
were available only from a fraction of the entire population. The numbers of speci-
mens are shown in Table 6. 
Table 6. Origin and number of clinical specimens in the 16-year laboratory 
surveillance of respiratory tract infections 
 Number of cases with 
Population group NPA only Paired blood 
specimens only 
NPA and paired 
blood specimens 
Total 
Military recruits 
and personnel 
1594 2606 2981 7181 
Children ≤17 
years of age 
2833 12 874 3719 
Health care 
workers 
178 78 223 479 
Municipal health 
care center pa-
tients 
586 3 5 594 
Insufficient infor-
mation available 
33 15 9 47 
Total 5214 2714 4092 12020 
 
 
Patients were diagnosed and treated at the former Central Military Hospital, Hel-
sinki, Finland, at health care centers of different garrisons of the Finnish Defense 
Forces, state and private health care centers, at the pediatric department of the North 
Karelian Central Hospital in Joensuu, Finland, and the Aurora Hospital infectious 
disease clinic, Helsinki, Finland. The age of the patients ranged from 0 to 96 years.  
Respiratory specimens were collected during the acute phase of the illness, usu-
ally within three days after the onset of symptoms. For identification of respiratory 
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pathogens, an NPA specimen was collected from both nostrils by a mucus extractor 
(Uno Plast A/S, Hundestad, Denmark). For that purpose, the catheter was inserted 
into the nostril (3 – 6 cm, depending on the age of the patient) before the vacuum 
was applied. The catheter was left in place for a few seconds in order to stimulate 
mucus secretion by the airflow, before it was slowly withdrawn. This procedure was 
repeated with the other nostril using the same catheter. Typically, 0.5 to 2.0 ml of 
mucus was obtained. Mucus remaining in the catheter was collected by flushing the 
tube with 1 – 2 ml of physiological saline solution. For serological diagnosis, acute 
and convalescent phase serum specimens were collected. The first serum sample 
was usually collected simultaneously with the NPA specimen, and the convalescent 
phase serum was taken 2 – 4 weeks later. NPA specimens were tested immediately 
after arrival in the laboratory. Remaining NPA material was stored frozen at -70°C. 
Serum specimens were stored refrigerated at 4ºC -8ºC or at -20ºC until tested. Each 
specimen was sent with a standardized referral form containing adequate patient 
information and data on clinical findings. 
4.5.1 Laboratory methods used in the 16-year surveillance 
NPA specimens were tested by TR-FIA for the presence of influenza A and influ-
enza B, parainfluenza viruses type 1, 2, and 3, RSV and adenovirus antigens 
(Halonen, Herholzer et al. 1996). From acute and convalescent serum specimens, 
antibodies against the same viruses and against M. pneumoniae were measured by 
CFT (Hawkes 1979). 
Clinical information and laboratory results were compiled in a Microsoft Access-
based in-house refined database. Results from antigen detection by TR-FIA and 
from serology by CFT were compared with each other and the occurrence of respira-
tory pathogens during the observation period as determined by both methods was 
recorded. 
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5 Results 
Results from the studies in the separate publications are presented only briefly here. 
The major part of this Results section is devoted to the 16-year surveillance study. 
  
5.1 Laboratory diagnosis of adenovirus infections (I) 
A total of 238 NPA specimens from military conscripts with an acute respiratory 
tract infection have been studied by conventional virus culture, rapid virus culture, 
PCR, EIA, and TR-FIA. With these five methods combined, adenovirus infections 
were detected in 157 (66 %) of these 238 specimens. PCR and conventional virus 
culture with IF confirmation proved to be the most sensitive methods, yielding 147 
and 146 positive results, respectively. Rapid culture and antigen detection by EIA 
and by TR-FIA were less sensitive. From 133 patients acute and convalescent phase 
serum specimens were available for testing by CFT. In 69 of these serum pairs, a 
diagnostic increase of adenovirus-specific antibodies could be measured. On the 
other hand, 22 patients were found adenovirus-positive by PCR and 17 by antigen 
detection methods but failed to mount a significant titre increase by CFT. 
 
5.2 Mycoplasma pneumoniae in the nasopharynx and in the 
middle ear fluid of children with acute otitis media (II) 
Of the 380 MEF specimens, 16 were found positive for M. pneumoniae by PCR. 
From seven of these 16 patients, an NPA was also available for testing, of which 
only one gave a positive result by PCR. Serological findings did not match well with 
PCR findings. In 225 serum pairs only 4 significant titer increases were noted by 
EIA or by CFT. Of the 16 children with a M. pneumoniae in the MEF as determined 
by PCR, none had a ≥4-fold titer increase. However, in four of these 16 serum pairs 
a significant titer decrease was noted. S. pneumoniae, H. influenzae and M. catarrhalis
were found in some specimens. One specimen was positive for parainfluenza virus 
type 3 and two for rhinovirus. 
5.3 Sputum proved to be the optimal specimen for the 
detection of M. pneumoniae by PCR (III) 
For 22 of 32 patients with an X-ray confirmed pneumonia, a diagnosis of M. pneu-
moniae could be established by PCR. From all these 22 patients, the sputum speci-
men harbored the pathogen. NPA and throat swabs proved to be less optimal, as 
with those specimens, 6 and 10 cases, respectively, would have remained undiag-
nosed. From 15 patients CFT provided a significant titer increase between acute and 
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convalescent phase sera. In nine serum pairs, the titers remained on a diagnostically 
high level. Sera were not available from 4 patients. (Note: one patient is missing in 
table 1 of separate publication III, page 289. Sputum, NPA, and throat swab speci-
men of this patient were negative by PCR. His M. pneumoniae antibody titer in both 
acute and convalescent serum was 256). 
 
5.4 Serological methods enhance the diagnostic accuracy in 
otitis media patients (IV) 
In 447 AOM events NPA and MEF specimens were collected during the acute phase. 
In addition, paired acute and convalescent phase sera were available for testing. For 
163 events a viral etiology could be established combining TR-FIA for antigen de-
tection, EIA for measuring antibodies to RSV, and CFT for six other common res-
piratory viruses. Thirty-four events yielded a virus finding by antigen detection and 
by serological methods. Serology alone yielded 81 and TR-FIA alone 48 positive 
results, respectively. RSV, adenovirus, and parainfluenza virus type 3 were the most 
frequently identified viral pathogens. 
 
5.5 The occurrence of seven common respiratory viruses and 
M. pneumoniae  
Over a period of almost 16 years 12,020 cases of acute respiratory infection were 
investigated by TR-FIA antigen detection and/or CFT serology (Table 7). One or 
more respiratory pathogens were identified in 5,343 (44.5 %) cases. NPA samples 
were available from 9,306 patients. Of those, 9,200 were tested for the presence of 
influenza A and B, respiratory syncytial, parainfluenza virus types 1, 2 and 3, and 
adenovirus antigens by TR-FIA. In 106 specimens the sample volume was insuffi-
cient to allow testing for all seven viruses, and thus the tests performed were se-
lected based on the prevailing epidemic situation. TR-FIA revealed 3,051 (32.8 %) 
virus-positive cases including 35 cases (0.38 %) with dual viral findings (Table 7). 
Paired serum specimens were obtained from 6,806 patients. Almost all of these se-
rum pairs have been tested by CFT for the presence of antibodies against the seven 
viruses and against M. pneumoniae. A four-fold or greater rise in antibodies against 
one or more antigens was detected in 3,431 (50.4 %) cases (Table 7). 
5.5.1 Seasonal variation of respiratory virus and M. pneumoniae infections 
The monthly number of specimens tested varied greatly over the 16-year observa-
tion period. The highest number of samples were received during the winter months, 
especially when there was a significant epidemic caused by influenza viruses or by 
RSV (Figure 1 and Figure 2). Figure 1 presents the monthly numbers of positive findings 
by TR-FIA, while serological observations with the number of diagnostic antibody rises 
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to different viruses and M. pneumoniae are presented in Figure 2. It should be noted 
that CFT data was no longer available in 2005. Adenoviruses were identified every 
year with peak epidemic activity mainly between December and April. Influenza 
epidemics were also observed every year and the majority of positive influenza find-
ings were observed between December and February or January and March depend-
ing on the year. Major influenza A virus epidemics were usually associated with the 
emergence of a new antigenic variant of the H3N2 subtype as was the case in the 
years 1998, 2002, and 2003. Exceptionally high numbers of influenza B virus infec-
tions were observed during the epidemic season 2002/2003, a season when influenza 
A virus was almost absent. During seven winter seasons (years 1990, 1992, 1994, 
1995, 1998, 2004 and 2005), very low or no influenza B virus activity was noted 
(Figure 1 and Figure 2). Parainfluenza viruses were found only sporadically and the find-
ings were more scattered throughout the year as compared to influenza viruses. Most 
of the parainfluenza virus infections were caused by type 3 according to the results 
obtained by TR-FIA. Sporadic cases of RSV were observed during any month of the 
year. However, major epidemic activity varied considerably from one year to an-
other and epidemic peaks were found in winter months and in spring as well as in 
late fall (Figure 1 and Figure 2). In addition to viruses, the epidemic activity of M. pneu-
moniae infections was monitored by serology and several outbreaks were identified 
during the 16-year surveillance period. These outbreaks often stretched over several 
months during fall, winter, and spring, and significant epidemics were observed in 
1991-1993, 1995-1996, 2000 and 2001 (Figure 2). 
5.5.2 Distribution of respiratory infections in different age groups 
To more systematically analyze the age-related morbidity caused by respiratory 
microbial pathogens, patients were classified in three age groups, children and ado-
lescents ≤17 years of age, young adults from 18 to 30 years, and adults >30 years of 
age. Patients younger than 18 years of age represented 31 % of the study population, 
those between 18 and 30 years 63 %, and individuals older than 30 years 6 %, re-
spectively (Table 6). Children under 5 years of age represented about 75% in the age 
group of children and adolescents.  From 47 patients no information about their age 
was available. In these age groups, the prevalence of different respiratory pathogens 
varied considerably. In individuals <17 years of age, RSV, influenza A, and adeno-
viruses were in that order the most common pathogens. Individuals between 18 and 
30 years of age showed a high incidence of adeno- and influenza A virus infections, 
which together accounted for 75 % of all viral findings in this age group. In indi-
viduals over 30 years of age, influenza A and B viruses were clearly the most pre-
dominant pathogens, while parainfluenza viruses, RSV and M. pneumoniae were 
less prominent. 
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5.5.3 Comparison of the diagnostic value of TR-FIA and CFT 
Next, the diagnostic power of viral antigen detection from NPA specimens by TR-
FIA and diagnostic antibody rises in paired serum specimens by CFT were com-
pared. In 4,092 respiratory episodes it was possible to obtain a complete set of clini-
cal samples, i.e., NPA and paired acute and convalescent phase sera, and most of 
these sets have been tested for all seven respiratory viruses (Table 8). A total of 
2,682 virus positive findings were identified by either TR-FIA or by CFT, and 1,115 
virus infections were diagnosed by both methods. A total of 343 virus findings were 
established by TR-FIA alone without a significant by CFT. On the other hand, 1,221 
virus findings by CFT could not be verified by TR-FIA (Table 8). 
5.5.4 Co-infections with multiple respiratory viral pathogens and M. 
pneumoniae 
In 392 cases (7.3 % of all cases with a diagnostic finding) two pathogens were iden-
tified for the same infection episode, in 334 cases by the serological test (Table 9). 
In 58 cases double infections were identified by both methods or only by TR-FIA 
(data not shown). Co-infections occurred in many combinations of the different 
pathogens and thus the frequency of specific viral pathogens seemed to follow a 
pattern, which reflected the overall frequency of certain viral infections. Thus co-
infections where adenoviruses or influenza A viruses were associated with each 
other or with another respiratory pathogen were most commonly seen. Three patho-
gens were identified simultaneously in 20 patients (Table 10) and, similar to double 
infections, adenoviruses and influenza A viruses were most commonly involved. 
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Figure 1. (on page 52) The seasonal occurrence of respiratory viruses in Finland 
over a period of 16 years from 1989 to 2005. Nasopharyngeal aspirates 
were collected from patients with an acute respiratory infection. The 
specimens were analyzed by TR-FIA for the presence of adeno-, influ-
enza A-, influenza B-, parainfluenza-, and respiratory syncytial viruses. 
The bars in the top panel represent the total number of specimens ana-
lyzed each month and the bars in the pathogen-specific panels represent 
the number of positive findings each month. 
Figure 2. (on pages 53 and 54) The seasonal occurrence of respiratory viruses and 
M. pneumoniae in Finland over a period of 16 years. Acute and conva-
lescent phase sera were collected from patients with an acute respiratory 
infection. Antibodies to adeno-, influenza A-, influenza B-, parainfluenza-, 
and respiratory syncytial viruses and to M. pneumoniae were measured 
by the complement fixation test. The bars in the top panel represent the 
total number of serum pairs analyzed each month and the bars in the 
pathogen-specific panels represent the number of positive findings each 
month. 
Figure 2 continued 
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Figure 3. Percentage of positive laboratory findings from patients with acute res-
piratory infection. The results are presented separately for the two seg-
ments of the population from whom the highest number of specimens 
have been received over the 16 year observation period from 1989 to 
2005, i.e., children less than 18 years of age and army conscripts and 
military personnel. Results from direct antigen detection by TR-FIA and 
serology by complement fixation are combined.
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6 Discussion 
In this thesis, molecular methods were developed for the detection of adenoviruses 
and M. pneumoniae from clinical specimens. These methods were thoroughly vali-
dated against conventional diagnostic methods using appropriately collected clinical 
samples from individuals with upper and lower respiratory tract infections. In addi-
tion, the TR-FIA method, developed at the Department of Virology, University of 
Turku, for the detection of seven common respiratory viruses, was introduced at the 
Laboratory of Respiratory Viruses of the National Public Health Institute in Helsinki. 
This method was applied for the rapid diagnosis of respiratory tract infections in 
different population groups. The diagnostic sensitivity and value of TR-FIA was 
evaluated in relation to CFT serology on several thousand patients. TR-FIA was 
used as primary method for the identification of respiratory viruses in this laboratory 
for over 16 years. Data obtained from this long-term study allow for an analysis of 
the temporal circulation of these pathogens in the Finnish population. 
During the 1950s and 1960s many important respiratory viruses were identified. 
As better understanding of their clinical relevance and epidemiological behavior 
accumulated, the need for more rapid and sensitive diagnostic methods became ob-
vious. Rapid diagnosis of viral respiratory tract infections was first attempted in the 
late 1950s in order to quickly identify influenza infections. The methods used at that 
time were virus culture and serology. Over the following decade the method of anti-
gen detection by immunofluorescence staining was introduced, and is, after refine-
ment, still in use in many laboratories. Specific reagents became available for the 
seven respiratory viruses that were believed to most frequently cause infections that 
require hospital treatment particularly of children: adenovirus, influenza virus types 
A and B, parainfluenza virus types 1, 2, and 3, and RSV. The classical studies of 
respiratory tract infections clearly demonstrated the importance of rhinoviruses and 
coronaviruses as causative agents of upper respiratory tract infections. However, 
these viruses were less frequently detected in hospitalized patients who apparently 
suffer from more severe infections. Only after sensitive and specific molecular 
methods became available in the late 1980s, a better understanding of the clinical 
significance of rhinoviruses and coronaviruses was obtained, and it is now clear that 
also these viruses can cause severe respiratory tract infections. Over the past 12 
years, several previously unknown respiratory viruses have been detected and char-
acterized. These include e.g. the human metapneumovirus, several coronaviruses 
(SARS, NL-63, HKU-1, MERS) and bocaviruses. Sophisticated molecular methods 
have played a central role in identification of these “novel” respiratory viruses, and 
these nucleic-acid based methods have quickly evolved into a corner stone in the 
virus diagnostic laboratory. Along with molecular methods, also immunological 
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methods for the detection of viral antigens evolved from fluorescent antibody testing 
via radio- and enzyme-immunoassay to TR-FIA and its more recent modifications. 
The TR-FIA method widely used in this thesis, proved to be a sensitive and specific 
technique that allowed for a rapid detection of these seven respiratory viruses at a 
reasonable cost. 
 
6.1 Detection of adenovirus DNA in adult patients with 
respiratory infections by PCR (I) 
Adenoviruses frequently cause outbreaks of respiratory infections particularly in army 
training centers. Sometimes these infections are clinically severe and require hospitaliza-
tion of the patient. At the time when the samples for this study were collected, the Cent-
ral Military Hospital was right next door to the laboratory, and close collaboration be-
tween the two institutions was established. Therefore, most samples have been collected 
at the Central Military Hospital, which also guaranteed optimal transport logistics for the 
specimens. At the time this study was performed, PCR was not yet established as a rou-
tine method for the detection of adenoviral infections. This study was one of the first to 
thoroughly compare several diagnostic methods, which helped to assess the true sensi-
tivity of the adenovirus PCR described in study I. 
Conventional culture in A549 cells with subsequent confirmation by indirect 
immunofluorescent staining and TR-FIA were performed on the fresh samples im-
mediately after their arrival at the laboratory. A high proportion of the samples, 
almost 60 %, were found adenovirus-positive by these methods. Similar sensitivity 
was found by PCR. Interestingly, samples collected on the first day of illness, were 
more often positive by PCR than by conventional virus culture. This finding might 
be explained by the fact that early during the course of the illness mucus production 
might be less prominent as compared to a later phase. A similar difference was also 
observed on the 7th day of the illness or later. Disappearance of infectious virus dur-
ing this stage of the disease likely explains this phenomenon. Rapid culture, antigen 
detection by EIA, and PCR were done on previously frozen samples. Although ad-
enoviruses are non-enveloped viruses, even one cycle of freezing and thawing may 
affect the sensitivity of tests performed later on. As shown in this study, rapid cul-
ture, TR-FIA and EIA were considerably less sensitive than conventional culture 
and PCR. Inactivation or aggregation of the viruses during storage may, at least in 
part, explain this reduced sensitivity.  
Obviously this freezing and thawing did not affect the yield of virus DNA for 
PCR testing because the extraction procedure is presumably efficient also for stored 
specimens. However, for rapid culture, TR-FIA, and EIA, the specimens were fur-
ther diluted in order to have sufficient material available for all tests. With this dilu-
tion factor, samples containing only minor amounts of adenovirus may thus have 
remained undetected. 
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EIA detected slightly more positive samples than TR-FIA. The difference in 
these two test principles is that EIA is based on polyclonal guinea pig and rabbit 
antisera while the immunoreagent in TR-FIA was a mouse monoclonal antibody. 
The high specificity of mouse monoclonal antibodies may contribute to a decreased 
sensitivity if only minor changes in the recognized epitope accumulate. 
Paired, acute and convalescent phase sera were available from less than half of 
the patients for testing by CFT. A minor fraction of patients with a positive adenovi-
rus finding failed to mount a diagnostic antibody response. On the other hand, CFT 
serology identified several additional adenovirus infections that would have gone 
undetected by all other methods. 
 
6.2 PCR for the detection of M. pneumoniae DNA in children 
with acute otitis media (II). 
This is one of the first studies where M. pneumoniae was detected from MEF speci-
mens of small children with acute otitis media. Culture of M. pneumoniae is cum-
bersome, labor-intensive, and often time-consuming, and therefore is of little value 
in the microbial work-up of patients with respiratory infections. Although the dis-
cussion continues whether or not to treat this frequent illness in small children with 
antibiotics, recent findings indicate that children receiving amoxicillin-clavulanate 
experience less often treatment failure as compared to children receiving placebo 
(Ruohola, Waris et al. 2009). The optimal choice of antibiotic may, however, require 
specific identification of the causative pathogen early during the course of the illness. 
To this end, PCR provides a sensitive, specific and rapid diagnostic method to detect 
M. pneumoniae. 
The 380 MEF specimens for this study were collected between 1994 and 1997. 
Epidemiological records from the Finnish National Infectious Diseases Register 
(available since 1995) indicate that during the years 1995, 1996, and 1997 M. pneu-
moniae was identified throughout the year. However, the number of Mycoplasma 
cases diagnosed during these years was relatively small. This may be due to insensi-
tive detection methods used in diagnostic laboratories at that time. 
The P1 gene was selected as target for the PCR test. P1 is a highly immunogenic 
protein to which most infected individuals mount an immune response (Jacobs, Stu-
hlert et al. 1988; Fink, Read et al. 1995; Tuuminen, Suni et al. 2001). With 569 base 
pairs, the amplification product is unusually large. The primers were selected in 
order to clone and express parts of the P1 protein. For diagnostic purposes only, a 
shorter amplification product would have been chosen. Yet the specificity of the 
amplified product was verified by Southern hybridization using a 5’-[32P]-labeled 
probe. Also the probe with 514 base pairs was, according to present criteria, un-
commonly long. These long amplification products and probe may have affected the 
sensitivity of the M. pneumoniae DNA-specific PCR. 
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Of the 380 MEF specimens, 16 were found positive by the M. pneumoniae PCR. 
For several reasons the significance of these findings remains uncertain. Firstly, for 
only 7 of the 16 patients with a M. pneumoniae –positive PCR finding in MEF, an 
NPA was available. Of those 7 samples, only one contained M. pneumoniae as 
shown by PCR. Second, by CFT serology a ≥4-fold titer increase was observed in 
only two of the 16 patients. A few titer decreases were found by IgG and IgM EIA 
and one by CFT. Third, and probably most importantantly, 11 of the M. pneumoniae 
PCR-positive MEF contained one or more bacteria frequently found in MEF of otitis 
media patients. In addition, 3 of the 16 specimens also harbored a common respira-
tory virus. Without the detection of cultivable M. pneumoniae organisms it remains 
difficult to estimate its role in the pathogenesis of acute otitis media. M. pneumoniae 
could be passively transported to the middle ear through the Eustachian tube after 
the epithelium has been damaged by a preceeding virus infection and eventually by 
negative pressure in the middle ear as has been demonstrated in connection with 
rhinovirus infection (McBride, Doyle et al. 1989). M. pneumoniae has been cultured 
from two patients presenting with otitis media with effusion (Okazaki, Akema et al. 
1989). 
 
6.3 The sensitivity of M. pneumoniae PCR is greatly influenced 
by the specimen type (III). 
During winter 2001/2002 M. pneumoniae caused outbreaks in garrisons. At that time, 
most patients with lower respiratory tract infections requiring hospital treatment 
were referred to the Central Military Hospital in Helsinki. This provided an excel-
lent opportunity to compare different types of clinical specimens for the diagnosis of 
M. pneumoniae by PCR. A diagnosis of M. pneumoniae infection could be estab-
lished for 22 of the 32 patients. In this relatively small group of patients, sputum 
appeared to be the optimal sample type, as M. pneumoniae was detected in all 22 
sputum samples. NPAs and throat swabs yielded only 16 and 12 PCR positive find-
ings, respectively. On X-ray examination, pneumonia was identified in all 32 pa-
tients. One can therefore assume that the infection process was still ongoing in the 
lungs at the time these specimens were collected. From these young military recruits, 
it was relatively easy to obtain a sputum sample that likely contained mucus 
coughed up from the lower respiratory tract with little saliva contamination. 
From children and from the frail elderly it is obviously more difficult to obtain a 
suitable sputum specimen. There is ongoing controversy about the optimal respira-
tory specimen for the detection of M. pneumoniae. Nasopharyngeal aspirates, naso-
pharyngeal and oropharyngeal swabs have been used as alternative samples. In a 
group of 42 children with an average age of 5 to 6 years and an X-ray confirmed 
lower respiratory infection, 21 were diagnosed with an M. pneumoniae infection 
based on serological findings by EIA. Of these 21 children, 12 were found positive 
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by PCR, 9 from the oropharyngeal swab and 9 from the nasopharyngeal swab 
(Michelow, Olsen et al. 2004). In a comparison of NPA and throat swabs, the latter 
sample proved to be slightly superior, mainly due to the fact that one third of the 
specimens contained inhibitors of PCR (Reznikov, Blackmore et al. 1995). Similar 
findings have been presented in another study, but there the difference was not stat-
istically significant, due to the small number of patients (Gnarpe, Lundback et al. 
1997).  
In the present study, the serological results strongly support the PCR findings. 
Acute and convalescent serum pairs were available from 20 of 22 patients with a 
PCR-positive result from the sputum specimen. Of those 20 patients, 15 had a ≥ 4-
fold titer increase and the remaining 5 patients had a CF titer of ≥256 already in the 
acute phase serum. Studying a large group of children with X-ray-confirmed pneu-
monia, IgM and IgG serology performed on acute and convalescent phase sera, 
proved to be much more sensitive than PCR performed on NPA collected during the 
acute phase of illness (Waris, Toikka et al. 1998). However, it appears based on the 
present and other studies that a combination of several clinical samples and labora-
tory methods is required in order to achieve optimal accuracy of M. pneumoniae 
diagnosis. 
 
6.4 Inclusion of serological methods significantly increases 
diagnostic findings in epidemiological studies of acute oti-
tis media in children (IV) 
Acute otitis media is a frequent complication of viral respiratory tract infections in 
children. The FinOM Studies in the 1990s provided an opportunity to collect several 
types of clinical samples including MEF, NPA, and serial serum samples for a thor-
ough diagnostic work-up of the otitis events in children. Presently, with the availab-
ility of molecular methods and of methods for rapid antigen detection, serology is 
rarely used for the identification of pathogens causing upper respiratory tract infec-
tions and their complications. 
In a carefully conducted study published 13 years ago (Heikkinen, Thint et al. 
1999), an almost similar number of AOM as in the present study (IV), were viro-
logically, bacteriologically, and serologically analyzed (Table 11). 
The age of the children included in the study by Heikkinen and colleagues 
(Heikkinen, Thint et al. 1999) was from 2 months to 7 years, while in the present 
study (IV), the children were ≤2 years of age. Heikkinen and co-workers used virus 
culture, virus antigen detection by immunofluorescence staining, and serology on 
acute and convalescent phase sera likewise done by fluorescent antibody 
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Table 11. Comparison of two rather similar acute otitis media studies in children.  
 Räty et al. 2004 Heikkinen et al. 1999 
No. of patients 447 456 
Research period 1994 - 1997 1989 - 1993 
Age range 2 months to 2 years 2 months to 7 years 
Virus in MEF 43 77 
Viral infection1 163 168 
 32 23 surivonedA
Influenza viruses 17 24 
Parainfluenza viruses 42 29 
 56 27 VSR
Enteroviruses N.D.2  27 
 
1Combination of results obtained from TR-FIA antigen detection and CF serology (Raty, Ziegler et al. 2004) 
including adenovirus, influenza A and B, parainfluenza viruses types 1, 2, and 3, and RSV; fluorescent anti-
body staining, virus culture, and serology (Heikkinen, Thint et al. 1999) including adenovirus, influenza vi-
ruses, parainfluenza viruses, enteroviruses, and RSV, respectively. 2N.D..= not done 
 
staining. Both studies have been conducted over several years and the distribution of 
viruses identified in these AOM events was astonishingly similar, although the study 
sites were geographically distinct. The findings of the studies are summarized in 
Table 11. 
The importance of M. pneumoniae as a possible cause of AOM has been dis-
cussed above (II). The present study focused on common respiratory viruses for 
which suitable laboratory tests were available. As shown by Heikkinen and col-
leagues (Heikkinen, Thint et al. 1999) and many others, a variety of other viruses 
can be detected in MEF samples when appropriate methods are applied  (Nokso-
Koivisto, Raty et al. 2004; Rezes, Soderlund-Venermo et al. 2009; Marom, Nokso-
Koivisto et al. 2012; Ruohola, Pettigrew et al. 2013; Stockmann, Ampofo et al. 
2013).  
 
6.5 Long-term laboratory surveillance of several important 
respiratory pathogens (this thesis) 
Over a period of 16 years, respiratory infections in certain segments of the Finnish 
population were monitored through virus- and M. pneumoniae-specific laboratory 
analyses. A total of 12,020 infection episodes of ARI or ILI were included. In 5,343 
patients (44.5 %) a respiratory virus or M. pneumoniae could be identified as a pos-
sible etiological agent either by antigen detection and/or by serology. A primary 
purpose of this surveillance was to collect specimens needed by the NIC  in order to 
determine antigenic and genetic characteristics of circulating influenza viruses. 
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Children and young adults were overrepresented in this surveillance. This sur-
veillance system was originally established in order to fulfill the responsibilities of 
the NIC of THL, i.e., to collect suitable clinical specimens for isolation and charac-
terization of seasonal influenza viruses. Since respiratory viruses spread efficiently 
in daycare centers and in garrisons, a large fraction of the specimens analyzed were 
from pediatric clinics and from military health care services. Some samples from 
adults were sent from occupational health care centers. The remaining specimens 
were contributed by public and private health care centers serving patients of all age 
groups. 
Influenza A epidemics of various size occurred during each year of observation. 
Often the first influenza cases were identified in October or November, but major 
epidemic activity was usually observed from January to March. Two exceptions to 
this were the years 1993 and 2003 when the epidemic peak occurred already in 
December or November/December, respectively. In these years new antigenic vari-
ants A/Beijing/32/92 (H3N2) and A/Fujian/411/2002 (H3N2), respectively, had 
started to spread internationally during the previous spring. In contrast to influenza 
A, there were five winter seasons with very few or no influenza B infections. 
In the spring of the years 1998 and 2005 single cases of influenza B findings 
were observed in the absence of a preceding epidemic in the country. It remains 
unclear whether travellers arriving from countries with influenza B activity have 
imported these cases. During five seasons, influenza A and influenza B were circu-
lating simultaneously (Fig. 1). 
Most of the adenovirus infections occurred in garrisons. Adenovirus infections 
were recorded almost every month of the year. Major adenovirus activity appeared 
before or simultaneously with influenza epidemics. 
While in the United States RSV epidemics occur annually (Langley and Ander-
son 2011), in Finland major RSV epidemics are observed at two year intervals dur-
ing the winter period, with a minor outbreak in the preceding spring (Waris 1991). 
In the present study, this biannual cycle was less pronounced and could be identified 
in the seasons 1991/1992, 1999/2000, 2001/2002, and 2003/2004. While most of the 
RSV-positive samples were from children, some cases were noted among military 
recruits and in other adults. Parainfluenza infections occurred both in children and in 
adults. The epidemic timing of these viruses was less pronounced than that of RSV. 
A survey in the United States revealed that parainfluenza virus type 1 caused epi-
demics every two years in the late summer and fall, type 2 caused only sporadic 
outbreaks and type 3 appeared every year with peak epidemic activity often during 
the summer months (Hall 2001). In the present analysis parainfluenza virus type 3 
was the most frequently detected type based on antigen detection. Most of the ob-
served parainfluenza cases were sporadic in children with neither major epidemics 
nor with years of high epidemic activity. 
Infections with M. pneumoniae were diagnosed in all age groups. However, since 
paired sera from small children were less frequently available, young adults and 
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individuals > 30 years, were overrepresented in this analysis. In the present study, 
direct detection methods for M. pneumoniae were not available, nor was IgM ser-
ology used, which appears to be the most useful diagnostic test to identify M. pneu-
moniae cases particularly in children (Waris, Toikka et al. 1998). However, 
serological analysis clearly showed significant yearly and seasonal variation in M. 
pneumoniae infections. 
In order to rapidly identify an etiologic agent in clinical specimens, methods for 
the direct detection of a pathogen are essential. In certain clinical cases and for epi-
demiological surveillance the value of serological methods should, however, not be 
underestimated. Restricting data analysis in the present study to viruses only, ser-
ology yielded significantly more positive findings than antigen detection. Most im-
pressively, adenovirus CF test yielded more than twice as many significant titer 
increases compared to the findings by TR-FIA in young adults. Adult patients likely 
seek medical assistance later during the course of an infection, at the time when the 
pathogen may already have been cleared from the upper airways but a diagnostic 
rise in the antibody levels can still be detected between acute and convalescent 
serum specimens. In addition, the antigen detection tests for adenoviruses appear to 
be suboptimal (Kunz and Ottolini 2010). For patients from whom NPA and paired 
serum specimens were available, serology produced clearly more diagnostic findings 
than TR-FIA with the exception of RSV. RSV infections typically occur in young 
infants, in whom the seroresponse to the infecting pathogen may be slow. With the 
sampling strategy used in this surveillance, diagnostic titer rises may therefore have 
gone undetected. It has been shown previously (Falsey and Walsh 2000) that ser-
ology is not a particularly sensitive and reliable method for identification of RSV 
infections. 
Combining antigen detection with serology surprisingly often revealed more than 
one etiological agent during one episode of respiratory infection. Multiple infections 
were particularly frequent among military recruits, with adenovirus and influenza 
being mostly involved. In 35 of the more than 9,000 NPAs investigated, two viruses 
were identified. Living conditions in garrisons and day-care centers may create sig-
nificant risk for respiratory infection, and pathogens can thus spread efficiently, 
causing concurrent outbreaks or subsequent infection episodes (Owens, Canas et al. 
2009). The number of daycare children included in this study may be too small to 
make estimations whether a similar frequency of infections with multiple viruses 
could be established. Using sensitive molecular methods for the diagnosis of upper 
respiratory infections, multiple microbial findings are common (Ruohola, Waris et al. 
2009), often making it difficult to determine the pathogen responsible for the symp-
toms or how each of the pathogens contributes to the clinical presentation. Surpris-
ingly, a recent study has shown that simultaneous virus findings correlate with less 
severe disease (Martin, Kuypers et al. 2011). On the other hand, young children with 
viral coinfections seem to experience more severe forms of pneumonia as compared 
to children with a single viral pathogen identified (Cilla, Onate et al. 2008). 
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In different age groups of the present study material the spectrum of viral patho-
gens varied. While in the age group ≤17 years, RSV, influenza A, adenovirus, and 
parainfluenza viruses predominated, adeno- and influenzaviruses were most often 
found in young adults. Adenoviruses have long been identified as common respira-
tory pathogens in military training centers often causing severe infections (Gray, 
Goswami et al. 2000; Gray 2006; Burke, Vest et al. 2011). In individuals over 30 
years of age, influenza A and B viruses were the pathogens most often detected, 
emphasizing the public health importance of influenza viruses in this section of the 
population. Also here, the uneven representation of age groups in this surveillance 
may have contributed to this finding.  
During the years this surveillance was conducted, antigen detection assays have 
been the cutting-edge technology for the rapid identification of respiratory patho-
gens in clinical samples. The sensitivity of the TR-FIA method compared well with 
other standard laboratory techniques (Halonen, Herholzer et al. 1996). Molecular 
methods have found their place in diagnostic laboratories in the late 1990s or later, 
and only with the availability of multiplex methods has this technology been more 
widely used for diagnostic and surveillance purposes. Both TR-FIA antigen detec-
tion and CF serology have been limited to viruses for which suitable diagnostic re-
agents have been available. Thus other important respiratory viruses, including 
rhino- and enteroviruses, parechoviruses, coronaviruses, human metapneumoviruses, 
and bocaviruses, have not been included in the present study. However, the results 
presented here show that these viruses and M. pneumoniae cause a significant frac-
tion of acute respiratory tract infections in different segments of the Finnish popula-
tion. Many national and international surveillance systems are limited to influenza 
viruses. Since none of the pathogens investigated in this study can reliably be identi-
fied by specific clinical symptoms, more broad-spectrum diagnosis and surveillance 
of respiratory pathogens is essential in order to make more accurate clinical deci-
sions and use more efficient preventive strategies. 
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7 Conclusions 
The studies presented in this thesis were initiated soon after sensitive and specific, 
practical and user-friendly methods for the rapid identification of respiratory viruses 
in clinical specimens became available. The TR-FIA, a central method in all studies 
presented, has been developed at the Department of Virology, University of Turku, 
in the early 1980s. This method has been transferred to and thoroughly validated at 
the Virology Unit of THL. Using this TR-FIA technique it has been possible to 
study the seasonal occurrence of certain respiratory viruses in different segments of 
the Finnish population, and to establish a laboratory-based surveillance of these 
viruses. This activity, among others, provided the NIC within the Virology Unit with 
suitable specimens for the isolation, identification, and characterization of influenza 
viruses circulating in Finland. As expected, RSV was the most commonly detected 
virus in children. But also other respiratory viruses were frequently found in this age 
group. Adenoviruses and influenza viruses were predominant in military recruits. 
The long-term surveillance study presented here does not reflect the composition of 
the entire Finnish population. A number of important respiratory viruses such as 
rhinoviruses, coronaviruses, hMPV and HBoV were not included in this surveillance. 
Thus, this surveillance does not provide a comprehensive epidemiological picture of 
the respiratory viruses in Finland. Yet, particularly child day-care centers and army 
garrisons offer optimal conditions for an efficient spread of respiratory pathogens. 
Nevertheless, a more systematic sampling strategy covering all age groups and geo-
graphic areas is currently being established. 
The TR-FIA method has been available for a limited number of respiratory vi-
ruses. This included the seven viruses previously thought responsible for a signifi-
cant fraction of more severe infections particularly in children. Several previously 
unknown respiratory viruses, such as the human metapneumovirus, bocaviruses, and 
“novel” coronaviruses, have been identified in the past 12 years. In addition, during 
recent years, better understanding of picornaviruses as causative agents of upper and 
lower respiratory tract infections has accumulated. With the availability of highly 
sensitive and specific molecular methods, the development of immunological tech-
niques for the detection of these viruses has been slow. TR-FIA is still a practical 
method that allows for testing of a considerable number of specimens. Results can 
be obtained in less than two hours after receipt of the specimen. Although molecular 
methods are increasingly becoming available in diagnostic laboratories, methods for 
rapid antigen detection will maintain an important role in the rapid diagnosis of 
respiratory infections. After completing the 16-year surveillance study presented 
here, TR-FIA has been replaced by multiplex PCR methods for the detection of 
respiratory infections in the Virology Unit. 
Conclusions 
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The inclusion of serological methods for the diagnosis of respiratory infections 
has significantly increased the number of relevant findings in the 16-year surveil-
lance presented here. Although it rarely produces a conclusive result in the acute 
phase of the disease, the value of serology should not be underestimated when per-
forming epidemiological studies. Particularly from small children, it may be difficult 
and impractical to obtain venous blood samples for the diagnostic purposes in un-
complicated respiratory infections. However, novel laboratory methods for the iden-
tification of specific antibodies are becoming available, which possibly could be 
performed by capillary blood or alternative specimens. This may provide new op-
portunities in the future for the use of serology. CF technology has been used in the 
16-year surveillance. Although immunoassays may be more sensitive, the CF 
method continues to be a valuable, high throughput screening method. 
Combining methods for virus antigen detection with serology revealed a con-
siderable number of respiratory infections with the involvement of more than one 
pathogen. Such infections have been particularly observed in young children and in 
military conscripts. This again underlines the fact that the spread of infectious 
pathogens is enhanced in such environments.  
All the laboratory tests used in this study have their limitations. Every laboratory 
test produces occasionally results in the grey-zone, which makes interpretation diffi-
cult or even impossible. Since this work was primarily perfomed for surveillance 
purpose rather than as clinical diagnostic service, a new specimen was requested 
only in exceptional cases. Without any doubts, false-negative results have been re-
ported. Borderline-positive results obtained by TR-FIA were further evaluated by a 
confirmatory test. Unclear serological results were verified by repeating the test. 
PCR results were based on reading the agarose gel in UV light or hybridization blots. 
In some cases subjective interpretation in such readings is unavoidable. In laboratory 
medicine, laboratories produce test results. However, the final diagnosis is estab-
lished by the treating physician who has the overview of all clinical findings and 
laboratory test results. 
Laboratory surveillance of microbial pathogens does not only help to identify the 
causative agent and direct doctors towards optimal treatment, but it may also help to 
identify the beginning of an epidemic with known or even with previously unknown 
pathogens.  
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